Scroll down to: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Speaker Index
Speaker | Date | Title | Download |
A | |||
Abboud, Camille | Mar 29, 2013 | CML and Systemic Mastocytosis: Therapy Updates | |
Dec 19, 2014 | Myeloid Sarcoma: Another Run of the Mill AML? | ➤ .pptx | |
Mar 17, 2017 | MDS/MPN Overlap Syndromes | ➤ .pptx | |
Dec 21, 2018 | Chronic Myeloid Leukemia: Updates, Challenges and Pitfalls in Case Management | ➤ .pptx | |
Abboud, Ramzi | Dec 1, 2017 | JAK/STAT Pathways and Immunomodulation After Hematopoietic Cell Transplantation and Other Immune Therapies | |
Feb 16, 2018 | Coagulation Abnormalities in Acute Promyelocytic Leukemia | ➤ .pptx | |
May 25, 2018 | Hairy Cell Leukemia | ➤ .pptx | |
Jan 11, 2019 | Invariant NKT Cells: Harnessing Their Immunoregulatory and Effector Functions | ||
Mar 8, 2019 | The Curious Case of Coagulopathy in the Night | ➤ .pptx | |
Achilefu, Sam | Feb 10, 2017 | Light Mediated Molecular Imaging and Treatment of Cancer | |
Ademuyiwa, Foluso | May 6, 2022 | Racial Disparities in Oncology: Challenges and Opportunities | |
Adkins, Doug | Apr 18, 2003 | Melanocortin-4 Receptor Mutations in Obesity | ➤ .ppt |
Sep 12, 2003 | Use of Myeloid CSF's During Therapy of AML | ➤ .ppt | |
Sep 10, 2004 | Therapy for Squamous Cell Carcinoma of the Head and Neck | ➤ .ppt | |
Apr 4, 2014 | What Every Budding (and Experienced) Oncologist Should Know About Nasopharyngeal SCC: the Fundamentals | ➤ .ppt | |
Jul 15, 2016 | Writing Chemo Orders: The Basics I Must Know and Implement | ||
Dec 15, 2017 | Current Clinical Investigations in Head and Neck Cancer at Washington University | ||
Afzal, Amber | Oct 21, 2016 | JAK2V617F Mutation Leading to Splanchnic Vein Thrombosis | ➤ .pptx |
Feb 24, 2017 | MEK Inhibitors in Myeloid Malignancies | ➤ .pptx | |
May 26, 2017 | Outcomes of Stem Cell Transplant in Myelofibrosis | ||
Mar 30, 2018 | Anemia in Myelofibrosis | ➤ .pptx | |
Jun 15, 2018 | BCL2 Inhibition in Myeloid Malignancies | ||
Feb 15, 2019 | Approach to Splanchnic Vein Thrombosis | ➤ .pptx | |
Jun 7, 2019 | CDK9 Inhibition in Acute Myeloid Leukemia | ||
Jun 12, 2020 | Clonal Leukocytosis | ➤ .pptx | |
May 21, 2021 | ASH Review 2020: Clonal Cytopenia of Undetermined Significance and Use of Statins for Hematological Malignancies | ➤ .pptx | |
Jan 21, 2022 | ASH 2021 Review: Clonal Cytopenia of Undetermined Significance | ➤ .pptx | |
May 27, 2022 | Thrombosis at Unusual Sites | ➤ .pptx | |
Dec 16, 2022 | Thrombosis at Unusual Sites | ➤ .pptx | |
Jan 27, 2023 | ASH Review 2022: Clonal Cytopenia of Undetermined Signigicance | ➤ .pptx | |
Ahlawat, Shivani | Oct 4, 2019 | Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Tumors - What Is the State of the Art Imaging? | |
Ahmed, Nabil | Oct 26, 2018 | A Homing System Targets Therapeutic T Cells to Brain Cancer | |
Allen, Steven | Oct 31, 2014 | Benefit of Sorafenib Treatment in a Patient With FLT3-ITD Positive Acute Myelogenous Leukemia | ➤ .pptx |
Mar 20, 2015 | Osteopetrosis and the Role of HSCT | ➤ .pptx | |
Amin, Manik | Dec 14, 2012 | Gastrointestinal Stromal Tumor (GIST) | ➤ .pptx |
Apr 5, 2013 | Malignant Pleural Mesothelioma | ➤ .pptx | |
Anderson, Kenneth | Nov 2, 2018 | Novel Therapeutic Strategies in Multiple Myeloma | |
Andritsos, Leslie | Nov 9, 2001 | Leukemia Cutis | |
Jan 18, 2002 | Post-transfusion Purpura | ||
Mar 22, 2002 | Acquired von Willebrand Disease | ||
May 3, 2002 | Hairy Cell Leukemia | ||
Jun 7, 2002 | Iron Deficiency Secondary to Celiac Disease | ||
Oct 18, 2002 | Thymoma | ➤ .ppt | |
Mar 28, 2003 | Methylene Tetrahydrofolate Reductase and Thrombosis | ➤ .ppt | |
Jan 16, 2004 | Castleman's Disease | ➤ .ppt | |
Jan 14, 2005 | Stem Cell Mobilization: Current Therapies and Future Directions | ||
May 27, 2005 | Clinical Trials of AMD3100 for Stem Cell Mobilization | ➤ .ppt | |
Anim, Samuel | Oct 30, 2009 | A Case of Failure to Thrive and Pancytopenia in a Toddler | |
Mar 12, 2010 | Bilateral Wilms' Tumor | ➤ .ppt | |
Apr 9, 2010 | Langerhans Cell Histiocytosis in Children | ➤ .ppt | |
Ansstas, George | Sep 26, 2008 | Update on Advanced Liver Cancer Treatments | ➤ .ppt |
Jan 16, 2009 | Multiple Myeloma: Review and Update | ➤ .ppt | |
Apr 10, 2009 | Treatment Options for Castrate-Resistant Prostate Cancer | ➤ .ppt | |
Jun 19, 2009 | Update on GIST | ➤ .ppt | |
Oct 2, 2009 | Refractory CLL: Treatment Approaches | ➤ .ppt | |
Oct 23, 2009 | Hairy Cell Leukemia | ➤ .ppt | |
May 14, 2010 | Pathogenesis of DLBCL | ➤ .ppt | |
Sep 10, 2010 | Update on Advanced Stage Melanoma | ➤ .ppt | |
Arora, Vivek | Dec 22, 2017 | Emerging Concepts in Bladder Cancer Management | |
Ataga, Kenneth | Feb 28, 2020 | Meeting Unmet Needs in Sickle Cell Disease | |
Atibalentja, Danielle | Apr 28, 2023 | Deciphering B-Cell Responses in a Pre-Clinical Model of MYC-Driven T-Cell Lymphoma | |
Atiq, Mohammad | Nov 4, 2022 | Exploring Immunocytokine Synergy With Chemotherapy in Metastatic Prostate Cancer | |
Auberle, Christine | Feb 3, 2023 | Immune Thrombocytopenia (ITP) in Pregnancy | ➤ .pptx |
Azok, Jill | Jan 23, 2009 | Antiphospholipid Antibody Syndrome in Children | ➤ .ppt |
B | |||
Bagegni, Nusayba | Nov 13, 2015 | Immunotherapy for Triple Negative Breast Cancer? | ➤ .pptx |
Feb 12, 2016 | Hemophilia, Inhibitors and Immune Tolerance Induction (ITI) Therapy | ➤ .pptx | |
May 20, 2016 | Clinical Approach to Hypereosinophilic Syndrome | ➤ .pptx | |
Mar 31, 2017 | Cancer Related Microangiopathic Hemolytic Anemia | ➤ .pptx | |
May 19, 2017 | Management of Leptomeningeal Disease | ||
Aug 25, 2017 | Overcoming Drug Resistance in HER2+ Breast Cancer | ||
Baggstrom, Maria | Mar 21, 2008 | Adjuvant Chemotherapy in Early Stage Lung Cancer | |
Bansal, Dhruv | Mar 6, 2020 | Choosing the Best Anticoagulant for My Patient | ➤ .pptx |
Mar 12, 2021 | Discovering an Immunologic Beachhead in the Prostate Tumor Microenvironment | ||
Barman, Stephen | Oct 30, 2015 | Cancer Stem Cells: A Therapeutic Target? | ➤ .pptx |
Jan 22, 2016 | Fungal Prophylaxis in AML | ➤ .pptx | |
May 13, 2016 | Biphenotypic Hepatobiliary Primary Liver Cancer | ➤ .pptx | |
Feb 24, 2017 | Direct Oral Anticoagulants in Chronic Kidney Disease | ➤ .pptx | |
Apr 7, 2017 | Urothelial Carcinoma: Review and Updates of Second-Line Treatment | ||
Oct 13, 2017 | Hemophilia: A Love of Bleeding | ➤ .pptx | |
Barone, Amy | Sep 17, 2010 | Acute Lymphoblastic Leukemia and Down Syndrome | ➤ .ppt |
Feb 18, 2011 | Acute Lymphoblastic Leukemia and the Significance of the Detection of Minimum Residual Disease (MRD) | ➤ .ppt | |
Apr 15, 2011 | The Significance of FKHR Mutations in Rhabdomyosarcoma | ➤ .ppt | |
Bartlett, Nancy | Mar 21, 2003 | Treatment of Early Stage Favorable Hodgkin's Disease | |
Sep 16, 2005 | Current Therapies for Advanced Stage Mycosis Fungoides | ➤ .ppt | |
Aug 26, 2016 | Hodgkin Lymphoma | ||
Sep 2, 2016 | Targeted Approaches to Diffuse Large B Cell Lymphoma | ||
Batista, Luis | Mar 1, 2019 | Closer to a Cure: Human Embryonic Stem Cells Help Identify Novel Molecular Targets in Telomeropathies | |
Baumann, Brian | Oct 30, 2020 | The Promise of Proton Therapy as Part of Concurrent Chemo-Radiotherapy | |
Bednarski, Jeff | Nov 3, 2006 | CNS Germinomas, Diabetes Insipidus, and Chemotherapy: Challenges in Management | ➤ .ppt |
Feb 2, 2007 | Thymic Carcinoma: Should Biology Dictate Therapy? | ➤ .ppt | |
Beer, David | Dec 2, 2005 | Gene and Protein-based Strategies for Lung Cancer Diagnosis and Prognosis | |
Bernal-Mizrachi, Leon | Oct 4, 2002 | Markers of Endothelial Injury in GVHD and TTP | ➤ .ppt |
Jan 10, 2003 | Cytokines, Angiogenesis, and Tumor Growth | ➤ .ppt | |
Feb 14, 2003 | Circulating Endothelial Precursors and Tumor Angiogenesis | ➤ .ppt | |
Jun 27, 2003 | Autoimmunity and Myelodysplastic Syndrome | ➤ .ppt | |
Oct 31, 2003 | A Multigenic Program Mediating Breast Cancer Metastasis to Bone | ➤ .ppt | |
Mar 12, 2004 | Tax-induced Tumors | ||
May 6, 2005 | The Role of NF-kB in Lymphomagenesis | ||
Bern, Michael | Apr 14, 2023 | Updates on Hemophilia Therapies | ➤ .pptx |
Bessler, Monica | May 31, 2002 | Dyskeratosis Congenita | |
Nov 21, 2003 | Dyskeratosis Congenita: RNA Processing Versus Telomere Maintenance | ||
Jan 14, 2005 | Dysfunctional Telomere Maintenance in the Pathogenesis of Myelodysplastic Syndromes | ➤ .ppt | |
Mar 24, 2006 | Telomere Length in Aplastic Anemia and Myelodysplastic Syndromes | ➤ .ppt | |
Jul 14, 2006 | Bone Marrow Failure | ➤ .ppt | |
Mar 16, 2007 | Complement Inhibition for the Treatment of Paroxysmal Nocturnal Hemoglobinuria: Results From the TRIUMPH/SEPHARD Study | ➤ .ppt | |
Apr 23, 2010 | Paroxysmal Nocturnal Hemoglobinuira 2010 | ➤ .ppt | |
Bhalla, Sanjeev | Jan 8, 2021 | Chest Imaging for the Oncologist | |
Bhamidipati, Pavan | Sep 25, 2015 | Cytokine Release Syndrome in Haplo Transplants is Dangerous! | ➤ .pptx |
Mar 18, 2016 | Role of Antiplatelet Therapy for Vasoocclusive Crisis in Sickle Cell Disease | ➤ .pptx | |
Apr 22, 2016 | Bone Strengthening Agents in Myeloma: New Developments | ➤ .pptx | |
Sep 9, 2016 | Post-ASCT Maintenance Therapy in Multiple Myeloma | ➤ .pptx | |
Jun 9, 2017 | IDH Mutations in AML and Novel Therapeutics | ||
Oct 20, 2017 | Recent Advancements in AML and Novel Therapeutic Strategies | ➤ .pptx | |
Bhatt, Sima | Mar 13, 2015 | Follicular Lymphoma: Pediatric Subtype | ➤ .pptx |
Apr 3, 2015 | Wilms Tumor With Intra-Atrial Thrombus | ➤ .pptx | |
Blinder, Morey | Feb 8, 2002 | Refractory ITP | |
Mar 8, 2002 | Glucose 6-Phosphate Dehydrogenase Deficiency | ||
May 21, 2004 | Iron Overload and Treatment With a New Iron Chelator | ➤ .ppt | |
Apr 29, 2005 | Azathioprine and Acquired Aplastic Anemia | ➤ .ppt | |
Nov 11, 2005 | Sickle Cell Trait and Sudden Death | ➤ .ppt | |
Jul 7, 2006 | Peripheral Blood Smears | ➤ .ppt | |
Jul 21, 2006 | Anemia | ➤ .ppt | |
Aug 4, 2006 | Bleeding Disorders | ➤ .ppt | |
Sep 1, 2006 | Diagnostic Hematology: Monoclonal Gammopathies and Hemoglobin Disorders | ➤ .ppt | |
Nov 3, 2006 | Unexplained Iron Deficiency Anemia | ➤ .ppt | |
Jul 11, 2008 | Overview of Anemia | ➤ .ppt | |
Jul 18, 2008 | Peripheral Blood Morphology | ➤ .ppt | |
Jul 25, 2008 | Disorders of Hemoglobin and Gammopathies | ➤ .ppt | |
Aug 1, 2008 | Bleeding, Blood Products and Transfusion Therapy | ➤ .ppt | |
Aug 22, 2008 | Sickle Cell Anemia | ➤ .ppt | |
Jul 10, 2009 | Overview of Anemia (I) | ➤ .ppt | |
Jul 17, 2009 | Overview of Anemia (II) | ➤ .ppt | |
Jul 24, 2009 | Disorders of Hemoglobin and Gammopathies | ➤ .ppt | |
Jul 31, 2009 | Bleeding, Blood Products and Transfusion Therapy | ➤ .ppt | |
Aug 28, 2009 | Sickle Cell Disease | ➤ .ppt | |
Jan 15, 2010 | The Study of Hemoglobinopathies at Washington University | ➤ .ppt | |
Jul 9, 2010 | Introduction and Anemia Overview | ➤ .ppt | |
Jul 16, 2010 | Laboratory Testing | ➤ .ppt | |
Aug 6, 2010 | Approach to Thrombocytopenia | ➤ .ppt | |
Jul 8, 2011 | Overview of Anemia | ||
Jul 22, 2011 | Bleeding Disorders | ➤ .ppt | |
Jul 6, 2012 | Overview of Anemia | ➤ .pptx | |
Aug 24, 2012 | Approach to Thrombocytopenia | ➤ .pptx | |
Jul 12, 2013 | Hospital Acquired Thrombocytopenia | ➤ .pptx | |
Aug 16, 2013 | Sickle Cell Disease | ➤ .ppt | |
Oct 11, 2013 | Treatment of Anticoagulant–Associated Bleeding | ➤ .ppt | |
Jul 18, 2014 | Treatment of Bleeding | ➤ .pptx | |
Aug 22, 2014 | Sickle Cell Disease | ➤ .ppt | |
Aug 29, 2014 | Approach to Thrombocytopenia | ➤ .pptx | |
Nov 14, 2014 | Exertional Sickling, ASH and the NCAA | ➤ .pptx | |
Jul 17, 2015 | Factor Replacement Therapy | ➤ .pptx | |
Aug 14, 2015 | Sickle Cell Disease | ➤ .ppt | |
Aug 28, 2015 | Hospital Acquired Thrombocytopenia | ➤ .pptx | |
Aug 5, 2016 | Factor Replacement Therapy | ➤ .pptx | |
Aug 26, 2016 | Approach to Thrombocytopenia in the Hospitalized Patient | ➤ .pptx | |
Oct 7, 2016 | Bleeding Disorders (II) | ➤ .pptx | |
Feb 10, 2017 | Iron Metabolism and Iron Deficiency Anemia | ➤ .pptx | |
Feb 17, 2017 | Disorders of Iron Overload | ➤ .pptx | |
May 12, 2017 | Sickle Cell Disease | ➤ .ppt | |
Jul 28, 2017 | Approach to the Treatment of Bleeding Disorders | ➤ .pptx | |
Aug 25, 2017 | Evaluation of Hemoglobinopathy and Thalassemia Syndromes | ➤ .pptx | |
Sep 29, 2017 | Bleeding Disorders (Part 2) | ➤ .pptx | |
Oct 27, 2017 | Approach to Thrombocytopenia in the Hospitalized Patient | ➤ .pptx | |
Apr 6, 2018 | Disorders of Metal Metabolism: Iron Overload and Copper Deficiency | ➤ .pptx | |
Aug 3, 2018 | Bleeding Disorders (Part 2) | ➤ .pptx | |
Aug 24, 2018 | Hematology Consultations in Hospitalized Patients | ➤ .pptx | |
Oct 19, 2018 | Evaluation and Treatment of Iron Deficiency Anemia | ➤ .pptx | |
Oct 26, 2018 | Disorders of Metal Metabolism: Iron Overload and Copper Deficiency | ➤ .pptx | |
Mar 15, 2019 | Laboratory Diagnosis of Hemoglobinopathies and Thalassemia | ➤ .pptx | |
Apr 12, 2019 | Laboratory Evaluation of Immunoglobulins | ➤ .ppt | |
Aug 2, 2019 | Bleeding Disorders Part 2 | ➤ .pptx | |
Aug 16, 2019 | Hematology Consultations in Hospitalized Patients | ➤ .pptx | |
Sep 20, 2019 | Iron Homeostasis and the Evaluation and Treatment of Iron Deficiency Anemia | ➤ .pptx | |
Sep 27, 2019 | Disorders of Metal Metabolism: Iron Overload and Copper Deficiency | ➤ .pptx | |
May 22, 2020 | COVID-19 Coagulopathy and Venous Thromboembolism | ➤ .pptx | |
Jul 24, 2020 | Bleeding Disorders - Part 2 | ➤ .pptx | |
Sep 4, 2020 | Disorders of Metal Metabolism: Iron Deficiency/Copper Deficiency | ➤ .pptx | |
Oct 2, 2020 | Disorders of Globin: Hemoglobinopathies | ➤ .pptx | |
Oct 9, 2020 | Inherited Disorders of Red Cells: Thalassemia Syndromes, Enzymopathies and Membrane Disorders | ➤ .pptx | |
Feb 26, 2021 | ASH Review 2020: Immune-Mediated Hematology | ➤ .pptx | |
Jul 16, 2021 | Bleeding Disorders Part 1 | ➤ .pptx | |
Aug 27, 2021 | Disorders of Metal Metabolism: Iron Deficiency/Copper Deficiency | ➤ .pptx | |
Sep 17, 2021 | Disorders of Globin: Hemoglobinopathies | ➤ .pptx | |
Sep 24, 2021 | Inherited Disorders of Red Cells: Thalassemia Syndromes, Enzymopathies and Membrane Disorders | ➤ .pptx | |
Jan 7, 2022 | ASH 2021 Review: Immune Hematologic Disorders | ➤ .pptx | |
Apr 1, 2022 | Disorders of Heme Biosynthesis: Porphyria | ➤ .pptx | |
Apr 29, 2022 | For the Win: Athletics and Hematology | ➤ .pptx | |
Jul 22, 2022 | Bleeding Disorders Part 2 | ➤ .pptx | |
Aug 12, 2022 | Disorders of Metal Metabolism: Iron Deficiency/Copper Deficiency | ➤ .pptx | |
Sep 9, 2022 | Disorders of Heme Biosynthesis: Porphyria | ➤ .pptx | |
Oct 7, 2022 | Disorders of Globin: Hemoglobinopathies | ➤ .pptx | |
Oct 21, 2022 | Inherited Disorders of Red Cells: Enzymopathies, Membrane Disorders, and Others | ➤ .pptx | |
Oct 28, 2022 | Thalassemia Syndromes and Iron Overload Disorders | ➤ .pptx | |
Jan 20, 2023 | ASH Review 2022: Red Cell Disorders | ➤ .pptx | |
Mar 10, 2023 | Acute Intermittent Porphyria | ➤ .pptx | |
Jul 21, 2023 | Bleeding Disorders (Part 1) | ➤ .pptx | |
Blum, Bill | Oct 19, 2001 | Cytogenetic Risk Factors in AML | |
Jan 4, 2002 | CML Overview | ||
Feb 8, 2002 | HLA Typing | ||
Sep 13, 2002 | Low-Dose TBI Plus Cyclophosphamide as a Conditioning Regimen for Donor Transplantation | ➤ .ppt | |
Jan 24, 2003 | FLT3: a Target for Molecular Therapy in AML | ➤ .ppt | |
Blumenthal, Gideon | Oct 21, 2016 | Clinical Trials and Drug Development in Oncology: FDA's Perspective | |
Blum, Kristie | Sep 28, 2001 | Apoptosis Review | |
Nov 2, 2001 | Anaplastic Large Cell Lymphoma | ||
Apr 26, 2002 | MALT Lymphoma | ||
Sep 20, 2002 | T-Cell Prolymphocytic Leukemia | ➤ .ppt | |
Jan 31, 2003 | Proteasome Inhibition in Hodgkin's Lymphoma | ➤ .ppt | |
Bolten, Kelly | Nov 19, 2021 | Clonal Hematopoiesis: A Window Into the Determinates and Complexities of Cancer Predisposition | ➤ .pptx |
Bolton, Kelly | Feb 3, 2023 | Germline Genetic Predisposition to Cancer: Paradigm Shifts and Practical Application in Oncology Care | |
Bose, Ron | Mar 21, 2008 | Understanding Oncogenic Tyrosine Kinases and Their Inhibitors Using Phosphoproteomics | ➤ .ppt |
Nov 3, 2017 | Her2 Activating Mutations and the Challenge of Variants of Unknown Significance (VUS) in Breast Cancer Patients | ||
Feb 17, 2023 | Trastuzumab Deruxtecan in Breast, Lung, and Gastroesophageal Cancers | ||
Boxer, Laurence | Nov 19, 2010 | Bone Marrow Failure: Childhood Disease in Adults and Adult Disease in Children | ➤ .ppt |
Brasington, Rick | Jul 27, 2012 | Overview of Immunosuppressant Therapy | ➤ .ppt |
Brenner, Warren | Oct 17, 2003 | Primary Amyloidosis: an Overview | ➤ .ppt |
Feb 13, 2004 | Management of Refractory ITP | ➤ .ppt | |
May 28, 2004 | Adjuvant Therapy for Non-Small Cell Lung Cancer | ➤ .ppt | |
Nov 12, 2004 | Philadelphia Chromosome Positive ALL | ➤ .ppt | |
Mar 18, 2005 | Hereditary Non-Polyposis Colon Cancer | ➤ .ppt | |
Feb 17, 2006 | Management of HER2/neu Positive Breast Cancer in the Adjuvant Setting | ➤ .ppt | |
May 12, 2006 | Splenic Marginal Zone Lymphoma | ➤ .ppt | |
Brossier, Nicole | Jan 27, 2017 | Bilateral Retinoblastoma | ➤ .pptx |
Apr 21, 2017 | Childhood Atypical Teratoid/Rhabdoid Tumors | ➤ .pptx | |
Broze, George | Jan 18, 2002 | Heparin Resistance; Unexplained Elevation of the PTT in a Patient on Warfarin | |
Apr 16, 2004 | A Patient With Thrombocytopenia and Congenital Heart Disease | ||
Jan 28, 2005 | Occult Malignancy in Patients With Idiopathic Venous Thromboembolism | ||
Sep 30, 2005 | Hemophiliac Admitted for Cardiac Cath and PCA | ➤ .ppt | |
Mar 14, 2008 | Young Woman With a Bleeding History | ➤ .ppt | |
Brunt, Michael | May 12, 2023 | Splenectomy for Hematologic Disease: A Surgeon's Perspective | ➤ .pptx |
Burkard, Mark E. | Aug 9, 2019 | Enhancing Precision of Breast Cancer Treatment | |
Burtness, Barbara | Mar 26, 2021 | The Emerging Therapeutic Landscape in Head and Neck Cancer | |
Butler, Sara | Oct 14, 2016 | Stimulating WBC, RBC and Platelets in 2016: Navigating the Options | ➤ .pptx |
Nov 17, 2017 | Stimulating WBC, RBC and Platelets in 2017: Navigating the Options | ➤ .pptx | |
Butt, Omar | Jun 17, 2022 | The Intersection of the Blood Brain Barrier, Neuro-Inflammation, and Neuro-Degeneration in Neuro-Oncology | |
C | |||
Calhoun, Cecelia | Jan 30, 2015 | Homozygous Protein C Deficiency | ➤ .pptx |
Apr 24, 2015 | Hypereosinophilic Syndrome | ➤ .pptx | |
Carson, Ken | Oct 5, 2007 | Post-Marketing Pharmacovigilance and Drug Evaluation: Is Your RADAR On? | |
Oct 12, 2012 | The 'Skinny' on Obesity and Cancer | ➤ .pptx | |
Dec 20, 2013 | Can We Cure Multiple Myeloma With Prevention? | ||
Cashen, Amanda | Sep 5, 2003 | Chemoprevention of Prostate Cancer | ➤ .ppt |
May 7, 2004 | Anaplastic Large Cell Lymphoma | ➤ .ppt | |
Oct 15, 2004 | True Histiocytic Lymphoma | ➤ .ppt | |
Mar 11, 2005 | Decitabine for the Treatment of AML | ➤ .ppt | |
Jan 6, 2006 | Autologous Stem Cell Transplantation as Initial Treatment of Diffuse Large B-cell Lymphoma | ➤ .ppt | |
May 26, 2006 | Treatment-Related AML Associated With Balanced Chromosome Translocations | ➤ .ppt | |
Oct 12, 2007 | Autologous Transplantation for the Treatment of Follicular Lymphoma | ➤ .ppt | |
Feb 21, 2014 | Transformed Follicular Lymphoma: What’s the Role of Stem Cell Transplantation? | ➤ .pptx | |
Cassidy, James | Oct 26, 2001 | Polymer-Linked Anthracyclines | |
Chakinala, Murali | Mar 11, 2022 | Chronic Thromboembolic Pulmonary Hypertension | |
Challen, Grant | Sep 18, 2020 | The Epigenetic Regulation of Hematopoietic Stem Cells: From Clonal Hematopoiesis to Myeloid Neoplasia | |
Chandarlapaty, Sarat | Nov 1, 2019 | Breast Cancer Resistance to Combination Endocrine Therapy: Mechanisms and Therapeutic Implications | |
Chang, Shao-Chun | Sep 7, 2001 | MGUS and Polyneuropathy | |
May 10, 2002 | Cryoglobulinemia | ||
Nov 8, 2002 | Castleman's Disease | ➤ .ppt | |
Chaudhuri, Aadel | Jan 17, 2020 | Cell Free DNA Liquid Biopsy: Tumor Surveillance, Risk Stratification and MRD Detection | |
Chawla, Jane | Nov 14, 2008 | The Natural Killer Cell Neoplasms: Can We Overcome Treatment-Resistance? | ➤ .ppt |
Jan 30, 2009 | Pharmacogenetics and Chemotherapy | ➤ .ppt | |
Feb 27, 2009 | Acute Intermittent Porphyria | ➤ .ppt | |
May 15, 2009 | Neoadjuvant Chemotherapy for Rectal Cancer | ➤ .ppt | |
Sep 11, 2009 | A Phase II Study of Gemcitabine and Pazopanib in Metastatic Pancreatic Cancer | ||
Nov 6, 2009 | In Pursuit of Personalized Therapy for Breast Cancer: Gene Expression Signatures | ➤ .ppt | |
Sep 17, 2010 | Breast Cancer Chemoprevention | ➤ .ppt | |
Chen, Kevin | Oct 19, 2012 | Molecular Profiling of Carcinomas of Unknown Primary | ➤ .pptx |
Jan 18, 2013 | Evolution of Treating Gastric Lymphomas | ➤ .pptx | |
Mar 22, 2013 | Treatment Questions in Chronic Phase CML | ➤ .ppt | |
Sep 6, 2013 | The End of Observation for Smoldering Multiple Myeloma? | ➤ .ppt | |
Feb 7, 2014 | 'The Angelina Effect' on Breast Cancer | ➤ .ppt | |
May 2, 2014 | No More Needles? Clinical Applications of Liquid Biopsy | ➤ .ppt | |
Sep 5, 2014 | Oligometastases: Curable Stage IV Cancers? | ➤ .pptx | |
Feb 20, 2015 | Top Five (Advances in Modern Oncology) | ➤ .ppt | |
Cherian, Mathew | Sep 25, 2009 | PARP (polyADP-ribose Polymerase) and PARP Inhibitors | ➤ .ppt |
Nov 6, 2009 | Genome Sculpting Mechanisms in Cancer | ➤ .ppt | |
Mar 19, 2010 | Mitosis Arrest Shields in the Therapy of Cancer | ➤ .ppt | |
May 14, 2010 | Blood Brain Barrier: Does It Matter? | ➤ .ppt | |
Sep 10, 2010 | High Dose Pemetrexed With Leucovorin Rescue | ➤ .ppt | |
Mar 11, 2011 | Peculiarities of the Malignant Stroma | ➤ .ppt | |
Apr 22, 2011 | Endotoxin Drip | ➤ .ppt | |
Nov 4, 2011 | Sequence Dependent Synergism and Antagonism: a Recipe for Scheduling Combination Chemotherapy | ➤ .ppt | |
Chheda, Milan | May 6, 2016 | Understanding the Basic Mechanisms Governing the Tumor Initiating Cell State | |
Dec 14, 2018 | Using Zika Virus to Target Glioblastoma Stem Cells | ||
May 20, 2022 | Tuning In: A Review of Psychedelics for Patients With Cancer | ||
Chia, Yee | Oct 31, 2008 | Role of Imaging in Oncology | ➤ .ppt |
Jan 30, 2009 | The Role of PET Imaging in Hodgkin's Disease | ➤ .ppt | |
Mar 20, 2009 | Neoadjuvant Therapy in Potentially Resectable Pancreatic Cancer | ➤ .ppt | |
Jun 19, 2009 | Neoadjuvant Endocrine Therapy for Hormone Receptor-Positive Breast Cancer | ➤ .ppt | |
Sep 18, 2009 | Hedgehog Signaling and Breast Cancer | ||
Oct 16, 2009 | Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE-MRI) | ➤ .ppt | |
Mar 19, 2010 | Going to Monte Carlo: the Use of Mathematical Modeling in Oncology | ➤ .ppt | |
Apr 1, 2011 | Dealing With Uncertainty in Evidence-based Medicine: Can Bayesian Approaches Complement Classical Biostatistics? | ➤ .ppt | |
Cho, Gus | Feb 14, 2020 | Mechanisms Regulating Intravascular Cell-Cell Interactions in Thrombosis and Inflammation | |
Nov 6, 2020 | Mechanisms Regulating Intravascular Cell-Cell Interactions in Thrombosis and Inflammation | ➤ .pptx | |
Christopher, Matt | Nov 9, 2012 | Donor Lymphocyte Infusions in AML | ➤ .pptx |
Mar 8, 2013 | TPO Signaling and Maintenance of Hematopoietic Stem Cells | ➤ .pptx | |
May 10, 2013 | T Cell Trafficking and Graft Versus Host Disease | ➤ .pptx | |
Nov 1, 2013 | Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome in Adults | ➤ .pptx | |
Feb 21, 2014 | Isocitrate Dehydrogenase Mutations and CNS Malignancy - What's Krebs Got to Do With Crabs? | ➤ .pptx | |
Apr 18, 2014 | Flt3 Inhibitors in AML | ➤ .pptx | |
Jan 9, 2015 | Steroid Refractory Graft Versus Host Disease: a Role For Endothelial Dysfunction? | ➤ .pptx | |
Feb 27, 2015 | MRD Measurement in AML | ➤ .pptx | |
Oct 16, 2015 | Idiopathic Cytopenia of Undetermined Significance, Clonal Hematopoiesis of Indeterminate Potential, and Aplastic Anemia | ➤ .pptx | |
May 11, 2018 | AML Relapse | ➤ .ppt | |
Apr 19, 2019 | AML and the Graft-Versus-Leukemia Effect | ||
May 19, 2023 | Improving the Graft-Versus-AML Effect | ||
Ciorba, Matthew A. | Jun 8, 2018 | Save IDO Inhibitors! A Role for Tryptophan Metabolism in Colon Cancer | |
Cittolin-Santos, Giordano | Feb 11, 2022 | Neoadjuvant Immunotherapy in NSCLC | |
Jun 23, 2023 | Small Cell Lung Cancer: Changes in Epidemiology and Recent Advances | ||
Clifton, Katherine | Mar 1, 2019 | Exploring Oral Therapy Options in Geriatric Oncology: Analysis of Toxicity and Efficacy Of CDK4/6 Inhibitors in Metastatic Breast Cancer | |
Cluster, Andrew | Sep 27, 2013 | Current Management Strategies in Unilateral Retinoblastoma | ➤ .pptx |
Jan 31, 2014 | IMAGe Syndrome | ➤ .pptx | |
Cohen, Ezra | Mar 24, 2017 | Immune Approaches in Head and Neck Cancer | |
Cohen, Jared | Feb 11, 2022 | The Changing Landscape of Treatment in DLBCL | |
May 26, 2023 | Advances in the Diagnosis and Treatment of Lymphatic Dysgenesis and the Emerging Role of the Medical Oncologist | ||
Cole, Oladipo | Apr 15, 2022 | Curative Therapies in Sickle Cell Disease | ➤ .pptx |
Nov 11, 2022 | Beta-Thalassemia: Is the Future Here? | ➤ .pptx | |
Cooper, Amber | Mar 14, 2014 | Fertility Preservation Strategies for the Cancer Patient | ➤ .pptx |
Coplin, Maggi | Sep 21, 2001 | Fludarabine-Resistant CLL | |
Oct 19, 2001 | Large Granular Lymphocytic Leukemia | ||
Feb 1, 2002 | Hereditary Elliptocytosis (alpha-Spectrin Defects) | ||
Sep 13, 2002 | Iressa (EGFR Antagonist) for Non Small Cell Lung Cancer | ➤ .ppt | |
Nov 15, 2002 | Staging of Locally Advanced Breast Cancer | ➤ .ppt | |
Apr 11, 2003 | Desmoplastic Small Round Cell Tumor | ➤ .ppt | |
Jun 20, 2003 | Treatment of Post-Thrombocythemic Myelofibrosis With Myeloid Metaplasia | ➤ .ppt | |
Jan 23, 2004 | 20 Year Old Girl With Ankle Pain (Adamantinoma-Like Ewing's Sarcoma) | ➤ .ppt | |
Apr 16, 2004 | Nonseminomatous Germ Cell Tumors: Brain Metastasis at Presentation | ➤ .ppt | |
Costa, Fernando F. | May 29, 2015 | Inflammation and Endothelial Cell Activation as Therapeutic Targets in Sickle Cell Disease | |
Covut, Fahrettin | Oct 23, 2020 | Cancer Associated Venous Thromboembolism | ➤ .pptx |
Jan 15, 2021 | Advances in Multiple Myeloma Treatment | ||
Oct 8, 2021 | Minimal Residual Disease in Multiple Myeloma | ||
Oct 29, 2021 | Frontline Treatment of Multiple Myeloma | ➤ .pptx | |
Feb 24, 2023 | CAR T-Cell and Bispecific Therapies for Relapsed Refractory Multiple Myeloma | ||
Crees, Zach | May 8, 2020 | Hematologic Complications Associated With COVID-19 | |
Crees, Zachary | Nov 22, 2019 | Bone Marrow Niche - Hematopoietic Stem Cell (HSC) Signaling and Therapeutic Implications for Peripheral Blood (PB) HSC Mobilization | |
Oct 23, 2020 | Glucocorticoids: Mechanism(s) of Action | ||
May 28, 2021 | The GENESIS Trial - CXCR4 Inhibition With Motaxafortide + G-CSF for Hematopoietic Stem Cell Mobilization in Multiple Myeloma | ||
Dec 3, 2021 | Immunophenotypic and Single-Cell Transcriptional Profiling of CD34+ Hematopoietic Stem and Progenitor Cells Mobilized With Motixafortide (BL-8040) and G-CSF Versus Plerixafor and G-CSF Versus Placebo and G-CSF: A Correlative Study of the Genesis Trial | ||
Crosby, Seth | Feb 15, 2008 | Genetic Analysis in the 21st Century: the State of the Art at the Genome Sequencing Center | ➤ .ppt |
Cullen, Kevin | Jan 25, 2002 | Molecular Determinants of Treatment Outcome in Head and Neck Cancer | |
Curiel, David T. | Feb 23, 2018 | Molecular Engineering of Adenovirus to Actualize Cancer Vaccines | |
D | |||
Dannenberg, Andrew | Sep 27, 2002 | COX-2: a Rational Target for Anti-Cancer Therapy | |
Day, Ryan | Dec 14, 2018 | Syk Inhibitors in Hematologic Disease | ➤ .pptx |
May 24, 2019 | Targeting Apoptosis in AML | ||
Jan 10, 2020 | Maintenance Therapy in AML/MDS | ||
Jul 2, 2021 | Core-Binding Factor Leukemias: Mechanism and Treatment | ||
Apr 8, 2022 | RUNX1 in Hematologic Malignancies | ||
De Jesus Pizarro, Rigoberto | May 26, 2023 | Chronic Liver Disease and Oral Anticoagulation | ➤ .pptx |
Dean, Jennifer | Sep 24, 2004 | Neonatal Stroke | ➤ .ppt |
Apr 22, 2005 | Bone Marrow Failure in Dyskeratosis Congenita | ➤ .ppt | |
Deininger, Michael | Jan 22, 2021 | A Critical Role for SIRT5 in Acute Myeloid Leukemia Metabolism | |
DeNardo, David | Jan 18, 2019 | Targeting the Pancreas Cancer Tumor Microenvironment to Improve Response to Immunotherapy | |
Denes, Alex | Jun 27, 2003 | Aromatase Inhibitors in Breast Cancer | ➤ .ppt |
Jan 29, 2010 | Medical Oncology at Washington University - a Brief History | ➤ .ppt | |
Desai, Monica | Sep 14, 2012 | The Role of EML4-ALK in NSCLC | ➤ .ppt |
Oct 26, 2012 | EGFR Targeted Therapy in GI Cancer | ➤ .ppt | |
Sep 20, 2013 | Breast Cancer After Treatment of Hodgkin Lymphoma: the 5 W's | ➤ .ppt | |
Dec 13, 2013 | Primary CNS Lymphoma: Look How Far We’ve Come | ➤ .ppt | |
Devarakonda, Sid | Nov 14, 2014 | Synonymous Mutations and Cancer: Is Silence Golden? | ➤ .pptx |
Jan 16, 2015 | PTCy (Posttranplantation Cyclophosphamide) | ➤ .pptx | |
May 1, 2015 | Benign Ethnic Neutropenia | ➤ .pptx | |
Jan 8, 2016 | Small Cell Lung Cancer | ➤ .pptx | |
Mar 11, 2016 | Microsatellite Instability | ➤ .pptx | |
May 20, 2016 | Genomic Landscape of Lung Cancer | ➤ .pptx | |
Feb 3, 2017 | Origins and Genomic Landscape of Small Cell Lung Cancer | ||
Nov 6, 2020 | Implications of Cancer-"omics" Studies for Clinical Practice | ||
Devine, Steve | Jan 17, 2003 | Stem Cell Transplantation for PNH | ➤ .ppt |
Oct 3, 2003 | Allogeneic Stem Cell Transplantation for Non-Hodgkins Lymphoma | ➤ .ppt | |
Dhanesha, Nirav | Oct 22, 2021 | Mechanistic Role of Neutrophil Integrin α9β1 in Thrombosis and Inflammation | |
Di Paola, Jorge | Oct 16, 2020 | Inherited Platelet Disorders (From the Bedside to the Bench) | ➤ .pptx |
Jan 13, 2023 | Von Willebrand Disease, Diagnosis and Treatment | ➤ .pptx | |
Aug 11, 2023 | Von Willebrand Disease: Diagnosis and Treatment | ➤ .pptx | |
DiPersio, John | Jan 24, 2003 | Lymphangiogenesis | ➤ .ppt |
Oct 24, 2003 | Bone and Marrow...Are They Related? | ➤ .ppt | |
Sep 3, 2004 | Chronic Myelogenous Leukemia | ➤ .ppt | |
Nov 18, 2005 | AMD3100 for Stem Cell Mobilization: Preclinical and Clinical Trials | ➤ .ppt | |
Dec 1, 2006 | Review of Washington University Mobilization Database | ➤ .ppt | |
Jan 22, 2010 | History of the Division of Oncology | ➤ .ppt | |
Jan 13, 2012 | Optimizing Stem Cell Transplantation | ➤ .ppt | |
Mar 24, 2017 | Targets and Approach to Acute Lymphoblastic Leukemia | ➤ .pptx | |
Apr 20, 2018 | Therapeutic Targeting of Hematologic Malignancies | ||
Mar 5, 2021 | Novel Approaches for Stem Cell Mobilization | ➤ .pptx | |
Dmitrovsky, Ethan | Jul 27, 2007 | Bidirectional Translational Research as a Tool for Discovery | |
Dolatshahi, Leili | Nov 12, 2010 | Immunosuppressive Therapy in Acquired Aplastic Anemia | ➤ .ppt |
Feb 11, 2011 | The Optimal Local Control for Parameningeal Rhabdomyosarcoma | ➤ .ppt | |
Doyle, Magella | Dec 16, 2022 | Transplant Oncology - Making New Strides in Cancer Care | |
Druley, Todd | Nov 4, 2005 | Chromosome 21 and Lymphoproliferation | ➤ .ppt |
Feb 24, 2006 | Hypermutability as a Mechanism of Carcinogenesis | ➤ .ppt | |
Sep 30, 2016 | Leukemia-associated Clonal Hematopoiesis Is a Ubiquitous Process in Normal Aging | ||
Du, Lingling | Oct 10, 2014 | Neoadjuvant Therapy in Resectable Pancreatic Adenocarcinoma | ➤ .pptx |
Dec 12, 2014 | A Curious Case of Liver Failure (Erythropoietic Protoporphyria) | ➤ .pptx | |
May 22, 2015 | Primary CD5+ DLBCL | ➤ .pptx | |
Oct 30, 2015 | Genetic Susceptibility of Lung Cancer | ➤ .pptx | |
Mar 25, 2016 | Desmoid Tumors | ➤ .pptx | |
Oct 14, 2016 | IDO Inhibition in Cancer Treatment | ||
Duncavage, Eric | May 24, 2019 | Myeloseq | ➤ .pptx |
E | |||
Eby, Charles | Jun 18, 2004 | A Mistaken Diagnosis of Familial ITP (May-Hegglin Anomaly) | ➤ .ppt |
May 6, 2005 | Warfarin Resistance | ||
May 19, 2006 | Homozygous Protein C Deficiency | ➤ .ppt | |
Aug 18, 2006 | Laboratory Testing for Venous Thromboembolism Risk Assessment | ➤ .ppt | |
May 18, 2007 | Thrombotic Complications During Treatment of Bleeding in Hemophiliacs | ➤ .ppt | |
May 16, 2008 | Hemoglobin-based Oxygen Carrying Substitutes: Another Setback | ➤ .ppt | |
Aug 29, 2008 | Laboratory Testing for Venous Thromboembolism Risk Assessment | ➤ .ppt | |
Apr 24, 2009 | ABO Incompatible Red Cell Transfusions: Incidence, Consequences, Management, and Prevention | ➤ .ppt | |
Aug 7, 2009 | Hemostasis and Thrombophilia Testing | ➤ .ppt | |
Aug 13, 2010 | Hemostasis Testing at Barnes-Jewish Hospital Uncovered | ➤ .ppt | |
Aug 20, 2010 | Role of Laboratory Testing for Venous Thromboembolism Risk Assessment | ➤ .ppt | |
Aug 12, 2011 | Role of Laboratory Testing for Venous Thromboembolism Risk Assessment | ➤ .ppt | |
Aug 3, 2012 | Role of Laboratory Testing for Venous Thromboembolism Risk Assessment | ➤ .ppt | |
Jul 26, 2013 | Role of Laboratory Testing for Venous Thromboembolism Risk Assessment | ➤ .ppt | |
Jul 25, 2014 | Role of Laboratory Testing for Venous Thromboembolism Risk Assessment | ➤ .ppt | |
Jul 24, 2015 | Role of Laboratory Testing for Venous Thromboembolism Risk Assessment | ➤ .ppt | |
Aug 19, 2016 | Laboratory Testing for Venous Thromboembolism Risk Assessment | ➤ .ppt | |
Sep 1, 2017 | Laboratory Testing for Venous Thromboembolism Risk Assessment | ➤ .ppt | |
Jul 27, 2018 | Laboratory Testing for Venous Thromboembolism Risk Assessment | ➤ .ppt | |
Jul 26, 2019 | Hemostasis Laboratory Testing: Selected Topics | ➤ .ppt | |
Jul 31, 2020 | Hemostasis Laboratory Testing: Thrombophilia and Selected Topics | ➤ .ppt | |
Aug 13, 2021 | Hemostasis Laboratory Testing: Thrombophilia and Selected Topics | ➤ .ppt | |
Sep 30, 2022 | Laboratory Testing for Venous Thromboembolism Risk Assessment | ➤ .ppt | |
Nov 18, 2022 | HIT and TTP Testing - Barnes and Beyond | ➤ .pptx | |
Eckstein, Olive | Feb 18, 2022 | Hemophagocytic Lymphohistiocytosis (HLH) | |
Edwin, Natasha | Nov 13, 2015 | Therapeutic Advances in Myelofibrosis | ➤ .pptx |
Feb 5, 2016 | Medical and Ethical Challenges in the Care of a Patient With Acquired Hemophilia | ➤ .pptx | |
Apr 1, 2016 | Physician Burnout in Oncology | ➤ .pptx | |
Mar 31, 2017 | Burnout Among Oncologists | ||
Apr 21, 2017 | Pancreatic Cancer Associated Thrombosis | ➤ .pptx | |
Sep 15, 2017 | Physician Immigration and the US | ||
Einhorn, Lawrence | Feb 2, 2018 | Testicular Cancer: Past History, Present Results and Future Perspectives | |
Ellis, Matthew | Mar 25, 2005 | Breast Cancer Classification by RNA Profiling | |
Jan 28, 2011 | Genomics and Breast Cancer | ||
Sep 28, 2018 | Breast Cancer Proteogenomics | ||
Eulo, Vanessa | Apr 26, 2019 | Immunotherapy in Advanced Sarcoma | |
May 17, 2019 | Pregnancy in Sickle Cell Disease | ➤ .pptx | |
Mar 6, 2020 | Hematologic Complications of Gastric Bypass | ➤ .pptx | |
Oct 16, 2020 | Advancing Therapies in Sarcoma | ||
Ezenwajiaku, Nkiruka | Sep 30, 2016 | Chronic Myelomonocytic Leukemia | ➤ .pptx |
Dec 16, 2016 | Targeted Therapy in AML: The FLT3 Story | ➤ .pptx | |
May 26, 2017 | Hepatic Veno-Occlusive Disease | ||
Jan 12, 2018 | Gene Therapy in Sickle Cell Disease | ➤ .pptx | |
Feb 9, 2018 | Mixed Phenotype Acute Leukemia | ||
Nov 9, 2018 | Molecular Classification of Triple Negative Breast Cancer | ||
Jan 11, 2019 | Chronic Myelomonocytic Leukemia | ➤ .pptx | |
F | |||
Fakhri, Bita | Sep 11, 2015 | The Never-Ending Story of Induction Chemotherapy in Head and Neck Cancer: To Induce or Not To Induce | ➤ .pptx |
Oct 23, 2015 | Modern Haploidentical Strategies | ➤ .pptx | |
Apr 8, 2016 | Ponatinib: Past, Present, and Future | ➤ .pptx | |
Nov 11, 2016 | Livin' on a Prayer: Double and Triple Hit Lymphomas | ||
Dec 16, 2016 | Stem Cell Transplantation in Systemic Sclerosis | ➤ .pptx | |
Oct 27, 2017 | Current and Emerging Treatment Strategies for Relapsed and Refractory Multiple Myeloma | ||
Jun 8, 2018 | Fifty Shades of GATA2 Mutation | ➤ .pptx | |
Fehniger, Todd | Sep 10, 2004 | GIST and Imatinib | ➤ .ppt |
Jan 21, 2005 | Acquired Hemophagocytic Lymphohistiocytosis | ||
Jun 10, 2005 | Lenalidomide Therapy for MDS | ➤ .ppt | |
Nov 11, 2005 | MicroRNA: a New Key to Unravel CLL Pathogenesis and Prognosis? | ➤ .ppt | |
Mar 10, 2006 | NK Cell Receptors, Their Ligands, and Allogeneic Stem Cell Transplantation for Myeloid Malignancies | ➤ .ppt | |
Dec 1, 2006 | Regulatory T Cells in Anti-Tumor Immunity | ➤ .ppt | |
Mar 23, 2007 | Emerging Therapies for Fludarabine-Refractory CLL | ➤ .ppt | |
Apr 18, 2008 | Lenalidomide Therapy for Lymphoma | ➤ .ppt | |
Mar 13, 2009 | Lenalidomide Therapy for Untreated Acute Myeloid Leukemia in Older (>60 Years) Adults | ➤ .ppt | |
Apr 10, 2015 | Natural Killer Cells: New Concepts and Clinical Translation for Cancer Immunotherapy | ||
Sep 16, 2016 | Natural Killer Cell Immunotherapy: Prime or Recollect? | ||
Mar 10, 2017 | Mastocytosis, LCH, (and HLH), Oh My | ➤ .pptx | |
Dec 15, 2017 | Translating Interleukin 15 for Cancer Immunotherapy | ||
Apr 8, 2022 | Activate and Recollect: Training Natural Killer Cells for Cancer Immunotherapy | ||
Fenske, Tim | Jan 3, 2003 | CD30 as a Target for Therapy of Hodgkin's Disease | ➤ .ppt |
Mar 7, 2003 | Post-transplant Lymphoproliferative Disorders: EBV Not Always to Blame | ➤ .ppt | |
Apr 18, 2003 | Renal Cell Carcinoma | ➤ .ppt | |
Jun 13, 2003 | Rituxan for Treatment of Idiopathic Factor VIII Inhibitors | ➤ .ppt | |
Oct 24, 2003 | C-Kit Mutations in Core Binding Factor Leukemias | ||
Mar 5, 2004 | C/EBP Alpha Mutations in the Pathogenesis and Prognosis of AML | ➤ .ppt | |
Jun 25, 2004 | Chronic Myelomonocytic Leukemia (CMML) | ➤ .ppt | |
Nov 19, 2004 | Hematologic and Dermatologic Abnormalities Following Targeted Expression of AML1/ETO in Mice | ||
Apr 15, 2005 | Gene Expression Profiling in Large Cell Lymphoma: Emerging Clinical Applications | ➤ .ppt | |
Ferraro, Francesca | Sep 9, 2016 | Bone Marrow Microenvironmental Control of Hematopoietic Stem Cell Trafficking | ➤ .pptx |
Jan 20, 2017 | Hypomethylating Agents in Acute Myeloid Leukemia | ||
May 19, 2017 | Secondary ALL (Acute Lymphoblastic Leukemia): A Real Entity? | ||
Jan 12, 2018 | Stem Cell Transplant for Sickle Cell Disease | ➤ .pptx | |
Jun 15, 2018 | From MGUS to MGCS: When the "Uncertain" Turns to "Ugly" | ||
May 3, 2019 | Do We Understand Favorable Risk Acute Myeloid Leukemia? | ||
Feb 14, 2020 | Measurable Residual Disease (MRD) in AML: Challenges and Opportunities for Intervention | ||
Feb 19, 2021 | T Cell Phenotypes at Diagnosis Distinguish Long From Standard Remissions After Chemotherapy in Normal Karyotype AML | ||
Ferris, Margaret | Oct 23, 2015 | Juvenile Myelomonocytic Leukemia | ➤ .pptx |
Mar 18, 2016 | Hydroxyurea in Pediatric Sickle Cell Patients | ➤ .pptx | |
Fiala, Mark | May 6, 2022 | Racial Disparities in Oncology: Challenges and Opportunities | |
Field, Joshua | Oct 8, 2004 | 5-Azacytidine: the "New" Treatment for MDS | ➤ .ppt |
Mar 4, 2005 | Sickle Cell Disease and Stroke | ➤ .ppt | |
Jun 24, 2005 | Platelet Refractoriness/Alloimmunization | ➤ .ppt | |
Jan 13, 2006 | Cold Agglutinin Syndrome Following Allergenic Transplant | ➤ .ppt | |
Mar 6, 2009 | Asthma as a Modifier of Sickle Cell Disease Severity | ➤ .ppt | |
Jan 15, 2010 | Sickle Cell Studies at Washington University | ➤ .ppt | |
Fields, Melanie | Nov 4, 2011 | Interstitial Pneumonitis Secondary to Preparative Regimens for Autologous Bone Marrow Transplant | ➤ .ppt |
Feb 24, 2012 | Moyamoya Syndrome and Sickle Cell Disease | ➤ .ppt | |
Fields, Ryan | Nov 13, 2020 | The Clonal Evolution of Metastatic Colon Cancer: Insights and Implications for Patient Care | |
Fitzhugh, Courtney | Feb 10, 2023 | Clonal Hematopoiesis Following Curative Therapies for Sickle Cell Disease | |
Foley, Nicole | May 27, 2022 | T-Cell Lymphomas and HSCT | |
Jun 16, 2023 | Personalizing Therapy for Patients With T-Cell Lymphomas | ||
Fong, Tom | Sep 16, 2005 | Renal Disorders in Multiple Myeloma | ➤ .ppt |
Feb 17, 2006 | Primary CNS Lymphoma | ➤ .ppt | |
Jan 19, 2007 | Copper Deficiency and Myelodysplasia | ➤ .ppt | |
May 4, 2007 | Tumors of the Small Bowel | ➤ .ppt | |
Jan 4, 2008 | EGFR Inhibitors in Advanced NSCLC | ➤ .ppt | |
Fracasso, Paula | May 16, 2003 | The Cell Cycle as a Target for Cancer Therapy: Early Drug Development of UCN-01 | |
Apr 21, 2006 | Targeting the EGF Receptor in Cervical Cancer | ➤ .ppt | |
May 25, 2007 | Concurrent Cetuximab, Cisplatin, and Radiation Therapy in Advanced Cervical Cancer | ➤ .ppt | |
Franses, Joseph | Apr 1, 2022 | Identifying and Targeting Metastatic and Microenvironmental Drivers in Hepatocellular Carcinoma | |
Frei-Jones, Melissa | Oct 21, 2005 | Pediatric Manifestations of FAP - Hepatoblastoma and the Role of APC | ➤ .ppt |
Feb 3, 2006 | Pheochromocytoma in a Young Child: Long Term Follow-up and Risk of Second Malignancy | ➤ .ppt | |
Friedman, Henry | Dec 12, 2003 | Management of Glioma | |
Frith, Ashley | Sep 21, 2012 | Lambert-Eaton Myasthenic Syndrome | ➤ .pptx |
Dec 21, 2012 | Fertility Preservation in Women Undergoing Gonadotoxic Treatment of Cancer | ➤ .pptx | |
Feb 8, 2013 | Arginine Deprivation as a Treatment in Select Cancers | ➤ .pptx | |
Oct 4, 2013 | Exploring and Exploiting MYD88 L265P in Waldenström's Macroglobinemia | ➤ .pptx | |
Dec 20, 2013 | Treatment of Recurrent or Refractory Testicular Cancer | ➤ .pptx | |
Feb 14, 2014 | Fetal and Neonatal Alloimmune Thrombocytopenia | ➤ .pptx | |
Sep 12, 2014 | Anthracycline Induced Cardiotoxicity | ➤ .pptx | |
Oct 31, 2014 | Erythroferrone: An Erythroid Regulator of Iron Homeostasis | ➤ .pptx | |
G | |||
Garcia, David | Mar 4, 2022 | Antiphospholipid Syndrome | |
Gauthier, Megan | Nov 6, 2015 | Central Nervous System Relapse of Neuroblastoma | ➤ .pptx |
Mar 11, 2016 | Paraneoplastic Syndromes in Neuroblastic Tumors | ➤ .pptx | |
Gauvain, Karen | Nov 9, 2001 | Secondary Acute Promyelocytic Leukemia | |
Jan 4, 2002 | Hemophagocytic Lymphohistiocytosis (Perforin Mutation in Familial Form) | ||
George, James | Feb 19, 2010 | ITP: Is the Management Paradigm Changing? | ➤ .ppt |
Getz, Gad | Jun 22, 2018 | Studying Response and Resistance to Therapy in Cancer | |
Ghobadi, Armin | Nov 13, 2009 | FLT3 Mutations and FLT3 Targeted Therapy in AML | ➤ .ppt |
Feb 5, 2010 | JAK2 Inhibitors | ➤ .ppt | |
Mar 5, 2010 | T Regulatory Cells in Stem Cell Transplantation | ➤ .ppt | |
Apr 30, 2010 | BiTE (Bi-Specific T-cell Engagers) | ➤ .ppt | |
May 21, 2010 | Donor Lymphocyte Infusion | ➤ .ppt | |
Mar 4, 2011 | ABO Incompatible Hematopoietic Stem Cell Transplantation | ➤ .ppt | |
May 13, 2011 | Chimeric Antigen Receptor (CAR) Based Adoptive T-cell Immunotherapy | ➤ .ppt | |
Oct 28, 2011 | Hematopoietic Stem Cell Mobilization | ➤ .ppt | |
May 25, 2012 | Pneumatosis Cystoides Intestinalis and Allogeneic Stem Cell Transplantation | ➤ .pptx | |
Jan 26, 2018 | CAR-T Cell Therapy | ||
Oct 19, 2018 | CAR-T Cell Therapy and Its Complications | ||
Gillanders, William | Jan 20, 2012 | Development of a Breast Cancer Vaccine | |
Ginzburg, Yelena | Apr 30, 2021 | Dysregulated Iron Metabolism in Polycythemia Vera: Bench to Bedside | |
Gladwin, Mark | Apr 9, 2021 | Hemolytic Anemia as a Mechanism for Vasculopathy and Pulmonary Hypertension in Sickle Cell Disease and Other Hemolytic Conditions | |
Goldsmith, Scott | Apr 26, 2019 | Unfolding the Unfolded Protein Response: Implications for Cancer Therapy | |
May 17, 2019 | How Dr. Robotnik (aka Eggman) Treats AML/High Risk MDS in the Elderly and Unfit | ➤ .pptx | |
Jan 17, 2020 | Bridgeton Landfill in Your Bone Marrow: Updates in Smoldering Myeloma | ➤ .pptx | |
Jan 15, 2021 | The Theory of Everything of Multiple Myeloma | ➤ .ppt | |
Goodgame, Bo | Sep 2, 2005 | Brain Metastases in Non-Small Cell Lung Cancer | ➤ .ppt |
Jan 27, 2006 | GIST: a Review and Update | ➤ .ppt | |
Apr 14, 2006 | Virus, Lymphoma, and Worms: Complications and Treatment of HTLV1 | ➤ .ppt | |
Nov 17, 2006 | Tailored Toxic Therapy: Identifying Platinum Resistance | ➤ .ppt | |
Mar 9, 2007 | Prognostic Value of FDG-PET for Early Stage Carcinomas | ➤ .ppt | |
May 16, 2008 | To Bleed or Not to Bleed: Adverse Effects of Anti-Angiogenics | ➤ .ppt | |
Apr 10, 2009 | Old Dogmas, New Tricks: the Changing Treatment of Advanced Non-Small Cell Lung Cancer | ➤ .ppt | |
Gopalan, Priya | Dec 16, 2005 | Targeted Therapies for Advanced Non-Small Cell Lung Cancer | ➤ .ppt |
Apr 7, 2006 | Fanconi Anemia | ➤ .ppt | |
Oct 27, 2006 | Neoadjuvant Endocrine Therapy in Breast Cancer | ➤ .ppt | |
Mar 16, 2007 | Ovarian Cancer | ➤ .ppt | |
Feb 29, 2008 | Tumor Angiogenesis | ➤ .ppt | |
Oct 10, 2008 | Bone Metastases in Solid Tumors | ➤ .ppt | |
Feb 6, 2009 | Bone Marrow Micrometastases | ➤ .ppt | |
Gotlib, Jason | Aug 23, 2013 | New Treatment Approaches for Systemic Mastocytosis | ➤ .pptx |
Govindan, Ramaswamy | May 2, 2003 | Anti-Emetics | ➤ .ppt |
Nov 19, 2004 | Adjuvant Therapy for NSCLC: Current Data and Emerging Issues | ||
Jan 25, 2008 | Cancer Metastases: a Twist in the Tale, the Story of Epithelial Mesenchymal Transitions | ||
Goyal, Sagun | Sep 25, 2009 | Hyperhemolytic Syndrome in SCD | ➤ .ppt |
Nov 20, 2009 | Bortezomib in the Treatment of AL Amyloidosis | ➤ .ppt | |
Feb 5, 2010 | Etanercept in the Management for Acute Graft-Versus-Host Disease | ➤ .ppt | |
Feb 26, 2010 | Resistance in CLL: Prognostication From Assessment of the P53 Pathway | ➤ .ppt | |
Apr 23, 2010 | Reviving Bendamustine | ➤ .ppt | |
Oct 8, 2010 | Diffusion-Weighted MR Imaging in Lymphoma | ➤ .ppt | |
Apr 15, 2011 | Targeting CD30 in Hematopoietic Malignancies...Evolution of Success | ➤ .ppt | |
Sep 16, 2011 | The Role of 90Y-Ibritumomab Tiuxetan (Zevalin®) in the Treatment of Follicular Lymphoma | ➤ .ppt | |
Mar 2, 2012 | Arsenic for the Treatment of APL – Not a Poison | ➤ .ppt | |
Graubert, Tim | Apr 12, 2002 | Molecular Biology of Acute Myelogenous Leukemia | |
Mar 25, 2005 | Genetics of Susceptibility to Alkylator-Induced Cancer | ➤ .ppt | |
Grierson, Patrick | Mar 31, 2017 | Immunotherapy in GI Malignancies | |
May 5, 2017 | Congenital Macrothrombocytopenias | ➤ .pptx | |
Jun 9, 2017 | NK Cell Lymphoma | ||
Feb 23, 2018 | Chemotherapy-Induced aHUS | ➤ .pptx | |
Apr 6, 2018 | Targeting the MAPK Pathway in Solid Tumors | ||
Apr 26, 2019 | Iron Overload | ➤ .pptx | |
Sep 13, 2019 | The MK2/Hsp27 Axis as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma | ||
Griffith, Malachi | Sep 25, 2020 | Immunogenomics Approaches to Identify and Characterize Neoantigens | |
Griffith, Obi | Jun 21, 2019 | Surveying the Genomic Landscape of Tumors and Tumor Models - The Next Frontier | |
Grommes, Christian | May 21, 2021 | Primary CNS Lymphoma: Current Concepts and Changing Therapeutic Perspectives | |
Grossman, Bill | Oct 12, 2001 | Loxoscelism (Brown Recluse Spider Bite) | |
Feb 1, 2002 | Autoimmune Neutropenia | ||
Apr 5, 2002 | Hyperammonemia | ||
Jun 21, 2002 | Hemophagocytic Syndromes | ||
Grossman, Brenda | Aug 21, 2009 | Transfusion Medicine Overview | ➤ .ppt |
Jul 30, 2010 | Transfusion Medicine Overview | ➤ .ppt | |
Aug 26, 2011 | Transfusion Medicine Overview | ➤ .ppt | |
Jul 13, 2012 | Transfusion Medicine Overview | ➤ .pptx | |
Aug 2, 2013 | Transfusion Medicine Overview | ➤ .pptx | |
Aug 15, 2014 | Transfusion Medicine Overview | ➤ .ppt | |
Aug 7, 2015 | Transfusion Medicine Overview | ➤ .ppt | |
Jul 29, 2016 | Overview of Transfusion Medicine | ➤ .ppt | |
Jan 20, 2017 | Apheresis for the Hematologist | ||
Aug 4, 2017 | Transfusion Medicine Overview | ➤ .ppt | |
Jan 5, 2018 | Apheresis for the Hematologist | ➤ .pptx | |
Aug 10, 2018 | Transfusion Medicine Overview | ➤ .ppt | |
Aug 9, 2019 | Transufsion Medicine Overview | ➤ .ppt | |
Aug 28, 2020 | Transfusion Medicine Overview | ➤ .ppt | |
Jul 30, 2021 | Transfusion Medicine Overview | ➤ .ppt | |
Aug 26, 2022 | Transfusion Medicine Overview | ➤ .pptx | |
Gu, Michael | Oct 5, 2001 | PC-SPES Herbal Supplements for Advanced Prostate Cancer | |
Feb 22, 2002 | Effects of Glutamate Receptor Antagonists on Tumor Growth | ||
Apr 5, 2002 | Cancer of Unknown Primary | ||
Apr 26, 2002 | NK T-cell Lymphoma | ||
Nov 1, 2002 | Management of AML in the Elderly | ➤ .ppt | |
Feb 28, 2003 | Regional Therapy of Liver Metastases From Colorectal Cancer | ➤ .ppt | |
May 9, 2003 | Solitary Plasmacytoma of Bone | ➤ .ppt | |
Nov 21, 2003 | Treatment of Gastroenteropancreatic Endocrine Tumors | ➤ .ppt | |
Guy, Daniel | Nov 3, 2017 | Heparin Induced Thrombocytopenia | ➤ .pptx |
Jan 26, 2018 | Age-Related Clonal Hematopoiesis | ||
Dec 14, 2018 | DIC - Diagnosis, Pathogenesis and Treatment(?!) | ➤ .pptx | |
Feb 8, 2019 | Bispecific Antibodies for Treatment of AML | ||
Jan 10, 2020 | Blastic Plasmacytoid Dendritic Cell Neoplasm | ||
H | |||
Hagemann, Andrea | Jun 9, 2023 | Prioritizing Gynecologic Cancer Prevention: Panel Testing, Preventive Surgeries, and More | |
Hall, Erin | Jan 29, 2016 | Rituximab in Pediatric Non-Hodgkin's Lymphoma | ➤ .pptx |
Apr 8, 2016 | Diamond Blackfan Anemia | ➤ .pptx | |
Hayashi, Robert | Jan 31, 2003 | Thrombolytic Therapy in the Neonate | |
Apr 30, 2004 | Brown Recluse Spider Bites | ➤ .ppt | |
Nov 2, 2012 | CT and Cancer Risks | ➤ .pptx | |
Hays, John | Dec 13, 2019 | Finding the Right Targets in Recurrent Ovarian Cancer | |
Heldermon, Coy | Sep 3, 2004 | Merkel Cell Carcinoma | ➤ .ppt |
Jan 28, 2005 | Chronic Lymphocytic Leukemia | ➤ .ppt | |
Jun 3, 2005 | Endocrine Therapy of Breast Cancer | ➤ .ppt | |
Oct 14, 2005 | Breast Cancer Biomarkers | ➤ .ppt | |
Mar 24, 2006 | Bevacizumab Use for Metastatic Breast Cancer | ➤ .ppt | |
Dec 15, 2006 | Her-2 or Not | ➤ .ppt | |
Mar 2, 2007 | Neoadjuvant Chemotherapy of Breast Cancer | ➤ .ppt | |
Oct 19, 2007 | Gene Therapy and the Mucopolysaccharidosis IIIb Mouse Model | ||
Dec 19, 2008 | Splenomegaly and Cytopenia: Please Wait for the Path! | ➤ .ppt | |
Held, Jason | Feb 7, 2020 | Cancer Biochemistry Through the Lens of Chemical and Redox Biology | |
Hensing, Whitney | Feb 7, 2020 | Heparin-Induced Thrombocytopenia: Interpreting the SRA | ➤ .pptx |
Jun 19, 2020 | Immunotherapy in TNBC: Advances in Early Stage Disease | ||
Feb 26, 2021 | Targeting HER2 Mutations in Cancer | ||
May 14, 2021 | Hematologic Complications: COVID-19 Vaccines | ➤ .pptx | |
Sep 24, 2021 | Targeting HER2 in Breast Cancer: New Drugs and Paradigms | ||
Herman, Angela | Feb 8, 2013 | Juvenile Myelomonocytic Leukemia: a Review | ➤ .pptx |
Mar 22, 2013 | Hepatitis Associated Aplastic Anemia | ➤ .pptx | |
Herzog, Brett | Dec 1, 2017 | Clonal Dynamics of Non-Small Cell Lung Cancer | |
Feb 16, 2018 | Drug-Induced Neutropenia | ➤ .pptx | |
May 25, 2018 | Anti-Phospholipid Syndrome and Thrombosis | ➤ .pptx | |
Jan 11, 2019 | Fibrosis Modulates Lung Cancer Immunity and Progression | ||
Mar 8, 2019 | Adult HLH: An Acquired Conundrum | ➤ .pptx | |
Jan 31, 2020 | Modeling Stromal-Induced Immunotherapy Resistance in Lung Cancer | ||
Hess, Brian | Oct 25, 2013 | Combating Secondary Resistance in EGFR Mutant Positive Adenocarcinoma of the Lung | ➤ .pptx |
Jan 17, 2014 | The Effect of IL-15 on Natural Killer Cells and Their Anti-Tumor Functions | ➤ .pptx | |
Apr 25, 2014 | Recent Genetic Discoveries in Myelofibrosis and Their Potential Effect on Prognosis | ➤ .pptx | |
Sep 26, 2014 | Therapeutic Options for Elderly Patients With AML Unfit for Intensive Chemotherapy | ➤ .pptx | |
Feb 6, 2015 | Adjuvant Treatment Options in Node Positive Prostate Cancer After Prostatectomy | ➤ .pptx | |
Apr 3, 2015 | What's Driving CAR T cell Therapy | ➤ .pptx | |
Apr 29, 2016 | Management of CLL Post BCR Pathway Inhibition | ➤ .pptx | |
Hickey, Karin | Mar 22, 2019 | Endocrine Disorders in Cancer Patients | |
Hickman, Scot | Oct 25, 2002 | Molecular Indicators of Prognosis in CLL | |
Mar 12, 2004 | Two Cases: (1) Malaria; (2) Colorectal Cancer With Persistently Elevated CEA Due to Medullary Carcinoma of the Thyroid | ➤ .ppt | |
Mar 11, 2005 | Evans Syndrome and Combined Variable Immunodeficiency | ➤ .ppt | |
Jan 13, 2006 | A Woman With a Kidney Mass and a Lumbar Spine Lesion (Renal Cell Carcinoma) | ➤ .ppt | |
Dec 12, 2008 | DVTs - Old and Potentially New Therapy Modalities | ➤ .ppt | |
Jan 22, 2010 | History of VA Hematology and Oncology | ➤ .ppt | |
Hirbe, Angela | Sep 23, 2011 | The Role of TPO Receptor Agonists in the Treatment of ITP | ➤ .ppt |
Feb 10, 2012 | The TIE2/Angiopoeitin 2 Axis as a Potential Anti-Cancer Target for Angiosarcomas | ➤ .ppt | |
Mar 30, 2012 | Anti-Tumor Effects of Bisphosphonates | ➤ .ppt | |
May 4, 2012 | Treatment Strategies for MPNSTs | ➤ .ppt | |
Nov 1, 2013 | Iron Deficiency Anemia and the Effects on Platelets | ➤ .ppt | |
Mar 28, 2014 | The Use of Radium 223 in Patients With Bone Metastasis and Castrate-Resistant Prostate Cancer | ➤ .ppt | |
Apr 25, 2014 | BRAF as a Potential Target in MPNSTs | ➤ .ppt | |
Jan 9, 2015 | Platinums in Triple Negative Breast Cancer | ➤ .ppt | |
Feb 27, 2015 | The Role of Transplant in Relapsed Ewing Sarcoma | ➤ .ppt | |
Mar 29, 2019 | Clinical Challenges in the Diagnosis and Management of Neurofibromatosis-associated MPNSTs | ||
Hodi, F. Stephen | Jun 30, 2017 | Combinatorial Approaches With Immune Checkpoint Blockade to Treat Cancer | |
Hong, David | Feb 12, 2021 | Cracking Open the Undruggable RAS | |
Hopman, Rusudan | Oct 5, 2012 | Treatment of Well-Differentiated Pancreatic Neuroendocrine Tumors | ➤ .pptx |
Feb 1, 2013 | Familial Myelodysplastic Syndromes | ➤ .pptx | |
Sep 27, 2013 | Primary Mediastinal B Cell Lymphoma | ➤ .pptx | |
Mar 21, 2014 | Locoregional Treatment Strategies for Hepatocellular Carcinoma | ➤ .pptx | |
May 9, 2014 | Antiphospholipid Syndrome | ➤ .pptx | |
Oct 3, 2014 | Targeting Gene Fusions in NSCLC: ALK and ROS1 | ➤ .pptx | |
Jan 30, 2015 | Cytogenetics Aberrations in Myeloma: Implications for Prognosis and Treatment | ➤ .pptx | |
Hsieh, James | Feb 24, 2006 | Overview of PPAR Family Proteins | ➤ .ppt |
Feb 22, 2019 | Clinical and Translational Kidney Cancer Research: Now & Future | ||
Hugge, Christopher | Mar 28, 2003 | Nijmegen Breakage Syndrome | ➤ .ppt |
Apr 25, 2003 | Methemoglobinemia | ➤ .ppt | |
Hu, Ian | Dec 11, 2020 | Translational Research at NCI | |
Hulbert, Monica | Oct 31, 2003 | Multifocal Osteosarcoma | |
Jan 23, 2004 | Spinal Cord Compression in Neuroblastoma | ||
Mar 26, 2004 | A Complex Hemoglobinopathy (Hgb Constant Spring and Hgb E) | ||
Huselton, Eric | Nov 6, 2015 | Hematologic Complications and Medical Therapy for Hereditary Hemorrhagic Telangiectasia | ➤ .pptx |
Feb 5, 2016 | Checkpoint Blockade Therapy in Hematologic Malignancies | ➤ .pptx | |
May 27, 2016 | Adjuvant Hormonal Therapy for Breast Cancer | ➤ .pptx | |
Oct 21, 2016 | BCR-ABL-Like ALL | ➤ .pptx | |
Jan 20, 2017 | BCL-2 Inhibition in CLL | ||
Nov 17, 2017 | Improving Outcomes After Allogeneic Tranplant: Risk Factors and Treatment of Relapsed AML | ||
Hu, Xiaoyi "Sherry" | Nov 12, 2010 | Mechanisms of Endocrine Resistance in Breast Cancer | ➤ .ppt |
Dec 10, 2010 | Gemicitabine-Induced Hemolytic Uremic Syndrome | ➤ .ppt | |
Feb 4, 2011 | New Treatment for Unresectable Pancreatic Cancer | ||
Apr 8, 2011 | RANK-Ligand Inhibition in the Treatment of Bone Metastases | ➤ .ppt | |
May 27, 2011 | Hereditary Transthyretin-Related Amyloidosis | ➤ .ppt | |
Oct 7, 2011 | Treatment for Trastuzumab-Resistant HER2 Breast Cancer | ➤ .ppt | |
Mar 9, 2012 | Treatment for High-Risk, Clinically Localized Prostate Cancer | ➤ .ppt | |
Apr 6, 2012 | Metastatic Castration-Resistant Prostate Cancer: Hitting Old Targets Better With New Agents | ➤ .ppt | |
Sep 7, 2012 | Neoadjuvant Treatment for HER2 Positive Breast Cancer | ➤ .ppt | |
May 3, 2013 | Adjuvant Endocrine Therapy for ER+ Breast Cancer | ➤ .pptx | |
I | |||
Iglesia, Michael | Jan 17, 2020 | Bleeding in Connective Tissue Disorders | ➤ .pptx |
Jun 12, 2020 | Predicting Response to Immunotherapy: PD-L1 and Beyond | ||
Dec 18, 2020 | Breast Cancer Subtypes at the Single-Cell Level: Results From the Human Tumor Atlas Network | ||
May 13, 2022 | Metastasis in Colorectal Cancer | ||
Jun 30, 2023 | Liver Metastasis: Seed and Soil | ||
Iravani, Amir | Feb 5, 2021 | Molecular Imaging of Cancer and Immune Response to Immunotherapy | |
J | |||
Jackups, Ronald | Mar 23, 2018 | Clinical Decision Support for Transfusion Medicine | ➤ .pptx |
Nov 9, 2018 | Automated Hematology | ➤ .pptx | |
May 15, 2020 | Cell-a-Vision: WBC Differentials in the Era of Artificial Intelligence | ➤ .pptx | |
Mar 19, 2021 | When Hematology Testing Goes Wrong: How to Troubleshoot Unexpected Results | ➤ .pptx | |
Sep 23, 2022 | Cell-a-Vision: WBC Differentials in the Era of Artificial Intelligence | ➤ .pptx | |
Jacobs, Miriam | Oct 20, 2017 | Immunotherapy in Metastatic Squamous Cell Head and Neck Cancer | |
Jun 7, 2019 | Use of Cytokine Induced Memory Like NK Cells for Relapsed Refractory AML | ||
May 8, 2020 | Diagnosis and Management of DIC | ➤ .pptx | |
Jun 12, 2020 | The Role of IL-15 as a Cancer Immunotherapy | ||
Apr 23, 2021 | The Role of Natural Killer Cells in Solid Tumor Immunotherapy | ||
Apr 22, 2022 | Applications of Memory-Like Natural Killer Cells for Head and Neck Cancer Immunotherapy | ||
Jacoby, Meagan | Nov 2, 2007 | Total Lymphoid Irradiation for HSCT Conditioning: From Mice to Humans | ➤ .ppt |
Apr 11, 2008 | Cancer Epigenetics: Overview of the Role of Methylation | ➤ .ppt | |
May 23, 2008 | The Use of RFVIIa in Combat and Civilian Trauma: Primum Non Nocere? | ➤ .ppt | |
Oct 10, 2008 | Treatment-Related MDS/AML | ➤ .ppt | |
Mar 6, 2009 | A Typical Medicine Patient With an Atypical Hematologic Problem | ➤ .ppt | |
Feb 26, 2010 | A Case of Chronic Myelomonocytic Leukemia | ➤ .ppt | |
Nov 2, 2018 | Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance | ➤ .pptx | |
Feb 15, 2019 | Can Measurable Residual Disease Monitoring Post-Transplant Improve Outcomes for MDS Patients? | ||
Jaffee, Elizabeth | Mar 19, 2021 | Pancreatic Cancer Is PRIMED to Become an Immunologic Disease | |
Jänne, Pasi | Jun 29, 2018 | New Therapeutic Stratgies for EGFR Mutant Lung Cancer | |
Jen, Emily | Nov 8, 2013 | Pediatric Thymoma: Current Treatments and Targeted Therapy Trials | ➤ .pptx |
Mar 28, 2014 | Diamond Blackfan Anemia: Current Treatments and a Possible Role for Leucine | ➤ .pptx | |
Jenkins, Russell W. | Mar 30, 2018 | Ex-Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids: Developing a Functional Precision Medicine Platform for Immuno-Oncology | |
Jin, Ramon | Oct 20, 2017 | Cancer Stem Cells in Solid Tumors | |
Feb 2, 2018 | Pathogenesis of the Hypercoagulable State Associated With Malignancy | ➤ .pptx | |
Apr 6, 2018 | Metaplasia: The Calm Before the Storm? | ||
Nov 9, 2018 | GI Organoids in Cancer Research | ||
Apr 26, 2019 | Vascular Endothelial Growth Factor Signaling in Development and Disease | ➤ .pptx | |
Sep 27, 2019 | Organoids to Study Upper GI Malignancies | ||
Apr 30, 2021 | The Role of SOX2 in Barrett's Esophagus and Esophageal Adenocarcinoma | ||
Johanns, Tanner | Oct 3, 2014 | Spectrum of HLH-Like Hypercytokinemic Syndromes: Potential for Therapeutic Interventions Based on Shared Pathophysiology | ➤ .pptx |
Feb 6, 2015 | The Immune System and the CNS: Implications for Immunotherapy | ➤ .pptx | |
Mar 13, 2015 | B Cell Dysfunction in Chronic GVHD | ➤ .pptx | |
Oct 16, 2015 | Molecular Classification of Glioma | ➤ .pptx | |
Jan 29, 2016 | The Hypermutator Phenotype in Glioblastoma: Potential Therapeutic Implications? | ➤ .pptx | |
Mar 4, 2016 | HCMV as a Target in the Treatment of Glioblastoma | ➤ .pptx | |
May 12, 2017 | hTERT as an Immunologic Target | ||
May 17, 2019 | Neoantigens as Therapeutic Targets in Glioblastoma | ||
Johnson, Bruce | Apr 28, 2006 | Impact of Epidermal Growth Factor Receptor Mutations on the Treatment of Lung Cancer | |
Johnson, Dane | Jun 5, 2020 | Cryopreservation of Sperm: An Update on Current Practices | ➤ .pptx |
Jungheim, Emily | Sep 19, 2008 | Fertility Preservation in 2008: Options for Patients Facing Gonadotoxic Therapies | ➤ .ppt |
Sep 29, 2017 | Fertility Preservation in 2017 at Washington University | ||
K | |||
Kabiri, Zahra | Apr 9, 2021 | Interrogating the Role of Ras and Wnt Signaling Intensity in Colorectal Cancer | |
Kahl, Brad | Oct 6, 2017 | Mantle Cell Lymphoma: The State of the State | |
May 28, 2021 | Management of Follicular Lymphoma in 2021 | ➤ .pptx | |
May 13, 2022 | How to Manage Mantle Cell Lymphoma in 2022 | ➤ .pptx | |
Kang, Yoon-A | Jun 24, 2022 | Decoding Cell Fate Decision Mechanisms to Modulate Lineage Output for Therapeutic Purpose | ➤ .pptx |
Kanter, Julie | Oct 27, 2006 | Malignant Mesenchymoma: a Review of the Literature and Treatment Options | ➤ .ppt |
Feb 23, 2007 | The Clinical Implications of Treating Patients With Li-Fraumeni Syndrome | ➤ .ppt | |
Kaufman, Charles | May 3, 2019 | Epigenetic Regulators of Melanoma Initiation | |
Kavali, Pavan | Jun 14, 2019 | Acute Pulmonary Embolism: PERTinent Details - IR Perspective | ➤ .ppt |
Keller, Jesse | Oct 25, 2013 | Reeboks or FOLFOX: Physical Activity as Adjuvant Therapy in Colorectal Cancer | ➤ .pptx |
Jan 31, 2014 | Iron Refractory Iron Deficiency Anemia | ➤ .pptx | |
Apr 4, 2014 | Proteomics and Multiple Myeloma | ➤ .pptx | |
Sep 26, 2014 | BRAF Mutant Colorectal Cancer | ➤ .pptx | |
Jan 23, 2015 | Antibodies in Multiple Myeloma | ➤ .pptx | |
Apr 17, 2015 | Impromptu Grand Rounds: Mastocytosis and T-Cell LGL | ➤ .pptx | |
Sep 18, 2015 | Uncommon Clots | ➤ .pptx | |
Key, Nigel | Jun 18, 2021 | Thrombosis and Sickle Hemoglobinopathies: The Red Cell Connection | |
Khoury, Hanna | Mar 15, 2002 | Update on Treatment of CML | |
Jan 9, 2004 | AML and HIV | ➤ .ppt | |
Kim, Alfred | Dec 17, 2021 | SARS-CoV-2 Vaccination in Autoimmune Diseases: Updates on Immunogenicity | |
Kim, Brian | Jan 29, 2021 | Therapeutic Approaches to Chronic Itch | |
Kim, Miriam | Dec 7, 2018 | Developing Chimeric Antigen Receptor T Cells for AML | ➤ .pptx |
Nov 15, 2019 | Developing Chimeric Antigen Receptor T Cells for Acute Myeloid Leukemia | ➤ .pptx | |
Knapp, Brendan | May 19, 2023 | Recent Updates in Risk Stratification and Management of Smoldering Myeloma | ➤ .ppt |
Knoche, Eric | Sep 30, 2011 | Vemurafenib: Mechanisms of Resistance and Secondary Skin Tumors | ➤ .ppt |
Feb 3, 2012 | CLL: the Role of the Microenvirnoment and Potential Targets for Therapy | ➤ .ppt | |
Mar 16, 2012 | Splenomegaly and Myelofibrosis | ➤ .ppt | |
May 4, 2012 | Metformin: Evidence for Cancer Prevention and Treatment | ➤ .pptx | |
Sep 28, 2012 | TAML/MDS Is a Preventable but Lethal Complication of Chemotherapy | ➤ .pptx | |
Mar 1, 2013 | Myelodysplastic/Myeloproliferative Neoplasms | ➤ .pptx | |
Sep 13, 2013 | ERCC1: a Diamond in the Rough or Just Another Quest in La Mancha | ➤ .pptx | |
Mar 7, 2014 | HFE Compound Heterozygosity: Same Gene Different Wash | ➤ .pptx | |
Mar 3, 2017 | CLL: a Journey to the Center of the Maze, or Just a Wayward Amble | ➤ .pptx | |
May 29, 2020 | "The Sun's Not Yellow, It's Chicken": Making Sense of HLH on the Heme Consult Service | ➤ .pptx | |
Kommareddy, Aruna | Oct 11, 2002 | Malignant Pleural Mesothelioma | |
Dec 20, 2002 | Venous Thromboembolism and Cancer | ➤ .ppt | |
Mar 21, 2003 | Gastrointestinal Stromal Tumors | ➤ .ppt | |
Apr 25, 2003 | Combined Modality Therapy for Esophageal Cancer | ➤ .ppt | |
Nov 14, 2003 | High Dose Estrogen Therapy in Metastatic Breast Cancer | ➤ .ppt | |
Jan 30, 2004 | Metastatic Non Small Cell Lung Cancer: Options for Patients With Poor Performance Status or Co-Morbid Conditions | ||
Jan 7, 2005 | A Phase II Randomized Study of Intermediate and High Dose Estradiol in Metastatic Breast Cancer | ➤ .ppt | |
Kopetz, Scott | Jan 6, 2017 | Targeting BRAF in Colorectal Cancer | |
Kornfeld, Stuart | Jun 28, 2002 | Hepcidin and the Anemia of Chronic Disease | ➤ .ppt |
Oct 17, 2003 | Heat Shock Protein 90: Molecular Target for Cancer Therapeutics | ||
Feb 18, 2005 | Mechanism of Action of IVIG in Treatment of ITP | ➤ .ppt | |
Mar 17, 2006 | Intravascular Hemolysis and Pulmonary Hypertension in Sickle Cell Disease | ➤ .ppt | |
Sep 22, 2006 | Molecular Origins of Chronic Myeloproliferative Disorders | ➤ .ppt | |
May 9, 2008 | The Tn-Polyagglutination/Hemolytic Syndrome - an Explanation After 50 Years | ➤ .ppt | |
Nov 14, 2008 | Use of Very Low Doses of Single Chain Bivalent Antibodies in the Immunotherapy of Cancer | ➤ .ppt | |
Jan 8, 2010 | History of the Division of Hematology 1938-1966 | ➤ .ppt | |
May 19, 2017 | Red Cell Metabolism and Hemolysis | ➤ .pptx | |
Kothari, Alok | Oct 19, 2012 | A Different Approach to Solid Tumors: Management of Bilateral Wilms Tumor | ➤ .ppt |
Jan 11, 2013 | Primary CNS Lymphoma in Pediatrics | ➤ .pptx | |
Krajewski, Ken | Sep 30, 2011 | Metastatic Progression Despite Chemotherapeutics | ➤ .ppt |
Nov 11, 2011 | The PSA Screening Controversy | ➤ .ppt | |
Feb 3, 2012 | Induction Therapy in Untreated Multiple Myeloma Autologous Stem Cell Transplantation Candidates | ➤ .ppt | |
Apr 13, 2012 | Updates From New ACCP Antithrombotic Therapy and Prevention of Thrombosis, 9th Edition | ➤ .ppt | |
Sep 7, 2012 | Newly FDA Approved Therapies in Advanced Breast Cancer: Summer 2012 | ➤ .pptx | |
Apr 26, 2013 | De Novo Myelodysplastic Syndromes | ➤ .pptx | |
Sep 6, 2013 | Management of Testicular Germ Cell Tumors | ➤ .pptx | |
May 2, 2014 | Induction Therapy in Acute Promyelocytic Leukemia | ➤ .pptx | |
Kramer, Michael | Jun 18, 2021 | Machine Learning for the Oncologist: How the Machines Can Help You Help Patients | |
Mar 25, 2022 | The Proteomic and Phosphoproteomic Landscapes of Acute Myeloid Leukemia | ||
Jul 7, 2023 | Nucleophosmin Mutations in AML: From the Cell to the Patient | ||
Kratzke, Robert | Nov 22, 2002 | Role of P16INKa in Mesothelioma and Lung Cancer | |
Krone, Ronald | Jan 15, 2016 | Cardiac Toxicity of Cancer and Cancer Chemotherapy: The Role of the Cardio-Oncologist | ➤ .pptx |
Kunter, Ghada | Jan 21, 2005 | Congenital Polycythemia | ➤ .ppt |
Jun 3, 2005 | Transient Myeloproliferative Disorder in Down Syndrome | ➤ .ppt | |
Dec 14, 2007 | CSF3R Mutations Confer a Strong Clonal Hematopoietic Stem Cell Advantage Via Activation of Stat5 | ➤ .ppt | |
Mar 18, 2011 | Blueberry Muffin Rash | ➤ .ppt | |
Kuperman, David | Sep 17, 2004 | Athracycline Induced Cardiomyopathy: Mechanisms and Prevention | ➤ .ppt |
Feb 4, 2005 | Graft Vs. Host Disease: Pharmacologic Prevention | ➤ .ppt | |
Jun 17, 2005 | Targeted Therapies in AML | ➤ .ppt | |
Oct 28, 2005 | Autologous Stem Cell Transplant for AML | ➤ .ppt | |
Mar 3, 2006 | Targeted Therapies for Squamous Cell Cancer of the Head and Neck | ➤ .ppt | |
Feb 9, 2007 | Induction Therapy for Squamous Cell Cancer of the Head and Neck | ➤ .ppt | |
Apr 27, 2007 | Autologous Stem Cell Transplants for Solid Tumors | ➤ .ppt | |
Jan 4, 2008 | HPV and Squamous Cell Cancer of the Head and Neck | ➤ .ppt | |
L | |||
Lau-Min, Kelsey | Jun 25, 2021 | Bridging the Evidence-To-Practice Gap in Cancer Care: The Precision Oncology Experience | |
Lee, Sunyoung | Mar 15, 2019 | Immune Profiling and Prognostication of Lung and Pancreatic Adenocarcinoma | |
Lenihan, Daniel | Nov 10, 2017 | Cardio Oncology: How Can We Improve Practice? | |
Dec 20, 2019 | Cardio-Oncology: A New Part of the Team | ||
Leonard, John | Feb 16, 2018 | New Developments in Lymphoma: Progress and Problems in Precision Therapy | |
Ley, Tim | Mar 28, 2008 | Genomics of AML | |
Jan 21, 2011 | Sequencing the AML Genome | ➤ .ppt | |
Sep 9, 2016 | Acute Myeloid Leukemia | ||
Jun 10, 2022 | AML Proteomics and Interactomics | ||
Liao, Andy | Oct 17, 2014 | Thrombosis in Myeloproliferative Neoplasms | ➤ .pptx |
Feb 13, 2015 | HER2 and Endocrine Resistance in Advanced Breast Cancer | ➤ .pptx | |
May 22, 2015 | Erdheim-Chester Disease | ➤ .pptx | |
Sep 11, 2015 | Sickle Cell Hepatopathy | ➤ .pptx | |
Dec 11, 2015 | Telomeropathies and Bone Marrow Failure | ➤ .pptx | |
Feb 12, 2016 | Tumor Associated Macrophages in Breast Cancer | ➤ .pptx | |
Mar 10, 2017 | Emerging Treatment Options in Cholangiocarcinoma | ||
Lim, Kian-Huat | Oct 9, 2009 | Aurora Kinases as Anticancer Targets | ➤ .ppt |
Dec 11, 2009 | Circulating Tumor Cells in Cancer Prognosis and Diagnosis | ➤ .ppt | |
Feb 12, 2010 | Hsp90 as Anti-Cancer Target | ➤ .ppt | |
Apr 9, 2010 | Targeting B-Raf in Melanoma: an Update | ➤ .ppt | |
May 7, 2010 | Depriving Cancer Cells of Amino Acids: From Asparaginase to Arginine Deiminase | ➤ .ppt | |
Feb 1, 2019 | Targeting the Innate Immune Inflammatory Pathway in Pancreatic Cancer | ||
Mar 3, 2023 | Targeting Tumor Innate Inflammation in GI Cancers | ||
Linette, Gerald | Feb 15, 2002 | Treatment of Advanced Melanoma | |
Apr 7, 2006 | Brain Tumor Update | ➤ .ppt | |
Apr 6, 2007 | Cancer Immunotherapy Update | ➤ .ppt | |
Apr 4, 2008 | New Agents in Metastatic Melanoma: Sorafenib | ➤ .ppt | |
Jan 27, 2012 | Monoclonal Antibodies for Human Cancer Therapy | ||
Feb 15, 2013 | Contemporary Management of Melanoma Brain Metastases | ➤ .pptx | |
Jun 28, 2019 | Immunological Ignorance of Solid Tumors | ||
Lingling, Du | Jan 22, 2016 | Erythropoietin-Stimulating Agent (ESA) and Thrombopoietin Receptor Agonist (TPO-RA) in Solid Malignancy | ➤ .pptx |
Link, Dan | Apr 9, 2004 | Shwachman-Diamond Syndrome | ➤ .ppt |
Apr 8, 2005 | G-CSF Receptor Mutation in Severe Congenital Neutropenia (Kostmann's Syndrome) | ➤ .ppt | |
Mar 10, 2006 | Endothelial Progenitor Cells to Induce Therapeutic Angiogenesis | ➤ .ppt | |
Mar 2, 2007 | Pathogenesis of Severe Congenital Neutropenia | ➤ .ppt | |
Sep 14, 2007 | Overview of Research in the Stem Cell Biology Section | ||
May 1, 2009 | Molecular Pathogenesis of Severe Congenital Neutropenia | ➤ .ppt | |
Nov 18, 2016 | Neutropenia | ➤ .pptx | |
Dec 1, 2017 | Neutropenia | ➤ .pptx | |
Sep 7, 2018 | Neutrophil Disorders | ➤ .pptx | |
Nov 22, 2019 | Neutrophil Disorders | ➤ .pptx | |
Aug 21, 2020 | Neutrophil Disorders | ➤ .pptx | |
Sep 3, 2021 | Neutrophil Disorders | ➤ .pptx | |
Nov 12, 2021 | Clonal Hematopoiesis: Etiology and Evolution | ||
Liu, Chang | Dec 9, 2016 | HLA Testing for Hematopoietic Stem Cell Transplantation | |
Lockhart, Craig | Sep 21, 2007 | Multidisciplinary Phase I Studies in Oncology: the New and Current Standard | |
May 22, 2009 | Pharmacogenomics in Cancer Clinical Trials | ➤ .ppt | |
Nov 15, 2013 | Differences in Perception of Conflict of Interest | ➤ .ppt | |
Nov 4, 2016 | Strategic Targeting of Esophageal Cancers: 2016 Update | ||
Logothetis, Constantine | Jun 9, 2023 | VEXAS Syndrome: The Past, Present, and Future | ➤ .pptx |
Lombardi, Donald | Mar 18, 2005 | Tetraspanins in the Progression of Human Cancers | |
Mar 3, 2006 | Tetraspanins in Normal Cellular Processes and Malignancy | ➤ .ppt | |
Mar 23, 2007 | Treatment and Biology of HER-2/Neu Gene Amplified Breast Cancer | ||
Lublin, Doug | Jul 28, 2006 | Transfusion | ➤ .ppt |
Jul 23, 2010 | Introduction to RBC Serology | ➤ .ppt | |
Jul 15, 2011 | Immunohematology | ➤ .ppt | |
M | |||
Ma, Cynthia | Nov 5, 2004 | Aromatase Inhibitors, Aromatase Gene and Aromatase Pharmacogenomics | |
Oct 20, 2006 | Adjuvant Chemotherapy for Estrogen Receptor Positive Breast Cancer: More Questions Than Answers | ➤ .ppt | |
Jan 18, 2008 | An Exploratory Study of UCN-01 in Combination With Irinotecan for the Treatment of Advanced Triple Negative Breast Cancer | ➤ .ppt | |
Oct 17, 2008 | Targeting Chk1 in TP53 Mutated Triple Negative Breast Cancer | ||
Apr 11, 2014 | PI3K Pathway Inhibition in Breast Cancer | ➤ .ppt | |
Jul 29, 2016 | Metastatic Hormone Positive Breast Cancer | ||
Oct 7, 2016 | CDK 4/6 in ER+ Breast Cancer | ||
Maher, Chris | Jun 16, 2017 | The Biological and Clinical Significance of Long Non-Coding RNAs | |
Mar 10, 2023 | Altered Noncoding Regulation Across Solid Tumors | ||
Majerus, Elaine | Oct 12, 2001 | Familial Adenomatous Polyposis | |
Feb 22, 2002 | Hemoglobin E/Beta-Thalassemia | ||
Mar 22, 2002 | Pyruvate Kinase Deficiency and 2,3-Bisphosphoglycerate | ||
Sep 6, 2002 | Diagnosis and Treatment of Multiple Myeloma | ➤ .ppt | |
Jan 17, 2003 | Von Hippel-Lindau Syndrome | ➤ .ppt | |
Feb 16, 2007 | Familial Thrombocytopenias | ➤ .ppt | |
Feb 1, 2008 | Survival on Mount Everest | ➤ .ppt | |
Feb 20, 2009 | Eculizumab and Atypical HUS | ➤ .ppt | |
Aug 5, 2011 | Evaluation of Thrombocytopenia | ➤ .ppt | |
Jul 20, 2012 | Bleeding Disorders | ➤ .pptx | |
Aug 9, 2013 | Bleeding Disorders | ➤ .pptx | |
Jul 11, 2014 | Bleeding Disorders | ➤ .pptx | |
Jul 10, 2015 | Bleeding Disorders | ➤ .pptx | |
Jul 15, 2016 | Bleeding Disorders | ➤ .pptx | |
Sep 23, 2016 | Idiopathic Thrombocytopenic Purpura | ➤ .pptx | |
Jul 21, 2017 | Bleeding Disorders | ➤ .pptx | |
Sep 22, 2017 | Idiopathic Thrombocytopenic Purpura | ➤ .pptx | |
Jul 20, 2018 | Bleeding Disorders | ➤ .pptx | |
Jan 25, 2019 | Idiopathic Thrombocytopenic Purpura | ➤ .pptx | |
Jul 19, 2019 | Bleeding Disorders | ➤ .pptx | |
Jul 17, 2020 | Bleeding Disorders | ➤ .pptx | |
Jun 11, 2021 | ASH Review 2020: Bleeding Disorders | ➤ .pptx | |
Jul 23, 2021 | Bleeding Disorders Part 2 | ➤ .pptx | |
Jan 28, 2022 | ASH 2021 Review: Bleeding Disorders | ➤ .pptx | |
Jul 15, 2022 | Bleeding Disorders | ➤ .pptx | |
Mar 24, 2023 | Paroxysmal Nocturnal Hemoglobinuria: Past, Present, and Future | ➤ .pptx | |
Jul 28, 2023 | Bleeding Disorders (Part 2) | ➤ .pptx | |
Majerus, Phil | Jan 9, 2004 | Lymphoplasmacytic Lymphoma | ➤ .ppt |
Feb 4, 2005 | Oral Iron Chelators | ➤ .ppt | |
Nov 17, 2006 | The Association of ITP With TTP in a Young Woman | ➤ .ppt | |
Jan 11, 2008 | A Case of Thrombosis | ➤ .ppt | |
Oct 24, 2008 | Iron Deficiency Vs. Anemia of Chronic Disease | ➤ .ppt | |
Jan 8, 2010 | History of the Division of Hematology 1966-2009 | ➤ .ppt | |
Maki, Robert | Jan 25, 2013 | Novel Therapeutic Strategies in Sarcomas More Common in Adult Patients | ➤ .pptx |
Malecek, Mary-Kate | Nov 16, 2018 | A Case of Polycythemia and Review of Management | ➤ .pptx |
May 24, 2019 | Novel Therapies in Primary CNS Lymphoma | ||
Oct 25, 2019 | Hematologic Complications of Pregnancy | ➤ .pptx | |
Nov 22, 2019 | Targeting the PI3K Pathway in Cancer | ||
Mar 12, 2021 | Prevention and Treatment of Secondary CNS Lymphoma | ➤ .pptx | |
Mann, Janelle | Jul 22, 2016 | The Ins and Outs of Anti-Emetics | |
Mardis, Elaine | Jan 7, 2011 | Large Scale Sequencing | ➤ .ppt |
Martin, Mike | Oct 13, 2006 | Management of a Jehovah's Witness With TTP | ➤ .ppt |
Dec 15, 2006 | Pemetrexed in Thoracic Malignancies | ➤ .ppt | |
Mar 30, 2007 | How Andy Warhol Treated Myelodysplastic Syndrome | ➤ .ppt | |
Feb 8, 2008 | Induction Therapy in Elderly AML (PubMed) | ||
Sep 19, 2008 | Management of the Advanced Phases of CML | ➤ .ppt | |
Dec 19, 2008 | Abigail, Ezekiel and Freireich | ➤ .ppt | |
Mast, Alan | Nov 20, 2015 | Insights Into Iron Metabolism and Iron Deficiency From Studies of Blood Donors | ➤ .pptx |
Mathews, Vikram | Oct 10, 2003 | Leukemic and Stromal Cell Interactions: Relevance to Therapy of Acute Leukemia | ➤ .ppt |
Mar 19, 2004 | Role of T Cell Depleted HLA Identical Sibling Stem Cell Transplantation for AML in CR1 | ➤ .ppt | |
Mauro, David | May 14, 2004 | Erbitux Pharmacogenomics: Genomic Strategies and Clinical Applications Towards Patient Selection | |
McDevitt, Michael | Apr 16, 2010 | Myelodysplastic and Myeloproliferative Disorders, Biological and Clinical Opportunities | |
McDonald, Sharon | Mar 7, 2008 | Malignant Rhabdoid Tumor of the Liver | ➤ .ppt |
Apr 11, 2008 | Donor Lymphocyte Infusions in the Pediatric Population | ➤ .ppt | |
McLeod, Howard | Mar 8, 2002 | 5-FU Pharmacogenomics | |
May 21, 2004 | What Will It Take to Move Beyond Anatomy-Based Therapy for Cancer? | ➤ .ppt | |
May 27, 2005 | Genetic Strategies to Find Predictors of Chemotherapy Effect | ➤ .ppt | |
Mehan, Paul | Oct 1, 2010 | The Evolving Role of the Serum Free Light Chain Assay in Plasma Cell Disorders | ➤ .ppt |
Feb 25, 2011 | Influenza in Cancer Patients | ➤ .ppt | |
Apr 8, 2011 | HPV-Associated Head and Neck Cancer | ➤ .ppt | |
May 27, 2011 | Gene Expression Profiling in Cancer of Unknown Primary | ➤ .ppt | |
Sep 9, 2011 | Choosing Concurrent Chemotherapy in Locally Advanced Head and Neck Cancer | ➤ .ppt | |
Feb 17, 2012 | HNSCC: the Induction Conundrum | ➤ .ppt | |
Apr 20, 2012 | Cetuximab in Locally Advanced HNSCC: If It Itches, Scratch It | ➤ .pptx | |
Sep 14, 2012 | Incurable HNSCC | ➤ .pptx | |
May 10, 2013 | 5-FU Heartache | ➤ .pptx | |
Mehta-Shah, Neha | Jan 12, 2018 | T-Cell Lymphomas: Where We Are and Where We Hope to Be | |
Jun 7, 2019 | Novel Therapies in T-Cell Lymphomas | ➤ .ppt | |
Dec 11, 2020 | T-Cell Lymphomas: Out of the Darkness and Into the Light | ➤ .pptx | |
Michel, Loren | Apr 23, 2004 | The Mitotic Checkpoint and Cancer-Opposing Effects on Tumorigenesis and Tumor Cell Death Depending on MAD2 Dosage | |
Mar 31, 2006 | A Role for the Trop-2 Receptor in Transformation and Tumor Maintenance | ||
Oct 31, 2008 | Analysis of Trop-2 Function in Epithelial Carcinogenesis | ||
Miller, Brian | Jan 29, 2021 | Defining Immune Mechanisms to Overcome Resistance to Immunotherapy | |
Miller, Jeffrey | Sep 22, 2017 | Novel Ways to Activate NK Cells to Treat Cancer | |
Mohamed, Ali | Oct 21, 2011 | Castrate Resistant Prostate Cancer Second Line Therapy | ➤ .ppt |
Mar 2, 2012 | Subsequent Line of Targeted Therapies for Advanced RCC | ➤ .ppt | |
Apr 6, 2012 | KSHV and Notch Proteins: Can We Do Better? | ➤ .ppt | |
May 18, 2012 | Splanchic Vein Thrombosis and Myeloproliferative Neoplasms | ➤ .ppt | |
Nov 9, 2012 | IV Iron in Cancer Related Anemia | ➤ .ppt | |
May 24, 2013 | "Lost in Transition" Fears of Cancer Survivors | ➤ .ppt | |
Oct 18, 2013 | Rising Serum PSA Following Prostatectomy | ➤ .ppt | |
Jan 24, 2014 | Superficial Vein Thrombosis | ➤ .ppt | |
Morgensztern, Daniel | Oct 28, 2005 | Neoadjuvant Therapy for Esophageal Cancer | ➤ .ppt |
Oct 13, 2006 | Carcinoma of Unknown Primary | ➤ .ppt | |
Nov 30, 2007 | Adjuvant Chemotherapy for Non-Small Cell Lung Cancer | ➤ .ppt | |
Nov 21, 2008 | Update on Small Cell Lung Cancer | ➤ .ppt | |
Oct 24, 2014 | Targeting EGFR in Patients with Advanced Stage NSCLC | ➤ .pptx | |
Aug 5, 2016 | Non-Small Cell Lung Cancer | ||
Moskowitz, Craig | Oct 13, 2017 | Hodgkin Lymphoma in the Near Future: Impact of Modern Nuclear Medicine, Radiotherapy, Brentuximab Vedotin and the Checkpoint Inhibitors | |
Mosley, James | Oct 6, 2006 | Malignant Peripheral Nerve Sheath Tumor | ➤ .ppt |
Feb 23, 2007 | Management of Mechanical Complications of Lung Cancer | ➤ .ppt | |
May 25, 2007 | Hormone-Refractory Prostate Cancer: Current Trends and Future Directions | ➤ .ppt | |
Feb 1, 2008 | Defining the Role of Cetuximab in Head and Neck Squamous Cell Carcinoma | ➤ .ppt | |
Apr 18, 2008 | Adrenocortical Carcinoma | ➤ .ppt | |
Oct 17, 2008 | Recent Advances in the Treatment of CLL | ||
Jun 12, 2009 | Treatment Trends for Soft Tissue Sarcomas | ||
Mukherjee, Sucharita | Nov 3, 2017 | HLH: Hemophagocytic Lymphohistiocytosis | ➤ .pptx |
Apr 20, 2018 | Systemic Mastocytosis | ||
N | |||
Nagaraj, Gayathri | Oct 16, 2009 | Glucocorticoids - a Clinical Conundrum | ➤ .ppt |
Feb 12, 2010 | Phosphoinositide 3-Kinase Pathway as Therapeutic Targets in Cancer | ➤ .ppt | |
Mar 5, 2010 | Epigenetics in Cancer Management | ➤ .ppt | |
Mar 26, 2010 | DNA Mismatch Repair Deficient Colorectal Cancer – an Emerging Distinct Subtype | ➤ .ppt | |
May 28, 2010 | Revisiting the Breast Cancer Host With "HER" Complex Family | ➤ .ppt | |
Oct 1, 2010 | Triple Negative/Basal-Like Breast Cancer: Current Concepts | ➤ .ppt | |
Mar 4, 2011 | The Cancer Biomarker Paradox: Challenges in the Pursuit of Personalized Medicine | ||
Apr 29, 2011 | KRAS and Beyond: Search for Valid Biomarkers in Colorectal Cancer | ➤ .ppt | |
Oct 21, 2011 | Multimodality Management of Brain Metastasis in Breast Cancer | ➤ .ppt | |
May 25, 2012 | Current Concepts in the Adjuvant Chemotherapy Management of Early Stage Breast Cancer | ➤ .pptx | |
Narla, Goutham | Apr 14, 2017 | Novel Therapies to Activate Tumor Suppressor Proteins for Cancer Treatment | |
Naughton, Mike | Feb 25, 2005 | Bisphosphonates in Oncology | ➤ .ppt |
Nervi, Bruno | Nov 18, 2005 | Biology of Stem Cell and Leukemia Cell Mobilization | ➤ .ppt |
Mar 17, 2006 | Novel Strategies to Control GVHD | ➤ .ppt | |
Nestor, Pat | Sep 14, 2001 | Methylation of RASSF1A Tumor Suppressor Gene | |
Jan 11, 2002 | COX Inhibitors and Prostate Cancer | ||
Mar 29, 2002 | Expression of Bone-Specific Proteins by Prostate Cancer Cells | ||
Sep 6, 2002 | Prophylactic Radiation Therapy for Bone Metastases in Prostate and Breast Cancer | ||
Feb 21, 2003 | The Role of Beta3 Integrin in Bone Metastasis | ➤ .ppt | |
Ngwube, Alexander | Oct 14, 2011 | HLH: a Wolf in Sheep Clothing | ➤ .ppt |
Dec 16, 2011 | Bone Marrow Failure Syndrome: a Case Report | ➤ .ppt | |
Apr 20, 2012 | Thrombotic Thrombocytopenic Purpura | ➤ .ppt | |
Nielsen, Gradon | Jan 25, 2019 | Economic Challenges in Modern Oncology and the Need for Innovation | |
Apr 5, 2019 | Treatment for Relapsed or Refractory Multiple Myeloma | ➤ .pptx | |
Oct 18, 2019 | High Value Cancer Care | ||
Nov 8, 2019 | Paroxysmal Nocturnal Hemoglobinuria | ➤ .pptx | |
May 7, 2021 | Impact of COVID on the Quality of Cancer Care Delivery | ||
Nizamuddin, Imran | Feb 3, 2023 | Gene Therapy for Sickle Cell Disease | ➤ .pptx |
Nolta, Jan | Nov 7, 2003 | The Potential for Stem Cell-mediated Tissue Repair | ➤ .ppt |
Feb 10, 2006 | Immunodeficient Mouse Models to Examine the Effects of Hypoxia on Adult Stem Cell Homing in Tissue Repair | ||
O | |||
Oh, Stephen | Aug 19, 2011 | Diagnostic Approach to Myeloproliferative Neoplasms | ➤ .ppt |
Aug 17, 2012 | Diagnostic Approach to Myeloproliferative Neoplasms | ➤ .pptx | |
Jan 18, 2013 | A Rare Case of Congenital Polycythemia | ➤ .pptx | |
Jan 19, 2018 | Polycythemia Vera and Essential Thrombocythemia | ➤ .pptx | |
Feb 1, 2019 | Polycythemia Vera and Essential Thrombocythemia | ➤ .pptx | |
Sep 13, 2019 | Polycythemia Vera and Essential Thrombocythemia | ➤ .pptx | |
Sep 18, 2020 | Polycythemia Vera and Essential Thrombocythemia | ➤ .pptx | |
Nov 20, 2020 | JAK2 the Future: Leveraging Dysregulated Inflammatory Cytokine Signaling Networks for Therapeutic Benefit in Myeloproliferative Neoplasms | ||
Feb 26, 2021 | ASH Review 2020: Myeloproliferative Neoplasms | ➤ .pptx | |
Oct 1, 2021 | Polycythemia Vera and Essential Thrombocythemia | ➤ .pptx | |
Orlowski, Robert | Apr 16, 2021 | Novel Antibody Drug Conjugates for Hematologic Malignancies | |
Oza, Aabha | Feb 3, 2017 | Pathologic and Pharmacologic Alterations of Hgb-Oxygen Binding | ➤ .pptx |
Apr 7, 2017 | Peritoneal Carcinomatosis: Intraperitoneal Chemotherapy and Cytoreductive Surgery | ||
Mar 30, 2018 | Venom-Associated Coagulopathy | ➤ .pptx | |
Oct 12, 2018 | Management of Advanced Renal Cell Carcinoma | ||
P | |||
Pachynski, Russell | Feb 26, 2016 | RARRES2/Chemerin: Its Role in Tumorigenesis, Leukocyte Trafficking, and Opportunities for Immunomodulation | ➤ .ppt |
May 25, 2018 | Chemerin in Cancer | ||
Pallera, Arnel | Sep 21, 2001 | Primary Breast Sarcoma | |
Pan, Chongj-Xian | May 5, 2023 | Translational Research to Address Unmet Needs in Bladder Cancer | |
Papageorgio, Chris | Jan 11, 2002 | Mastocytosis | |
Park, Haeseong | May 29, 2020 | COVID-19 and Cancer | |
Patel, Bindiya | Apr 23, 2021 | Treatment Updates for Hemophilia | ➤ .ppt |
Mar 25, 2022 | Biomarkers to Guide Adjuvant Therapy in Early-Stage NSCLC | ||
Jun 10, 2022 | Risk Stratification and Thromboprophylaxis for Venous Thromboembolism in Patients with Cancer | ➤ .ppt | |
Apr 7, 2023 | Targeting MET in NSCLC | ||
Patel, Dilan | Feb 5, 2021 | Bone Marrow Transplantation for Sickle Cell Disease | ➤ .ppt |
Nov 12, 2021 | Common Principles Across Cytokine Storm Disorders | ➤ .pptx | |
Patnaik, Akash | Mar 31, 2023 | Activating Innate Immunity in Prostate Cancer: From Bedside to Bench and Back | |
Peddi, Parvin | Sep 24, 2010 | CNS Toxicities of Chemotherapy | ➤ .ppt |
Nov 5, 2010 | Advanced Refractory NSCLC: Is Gemcitabine Monotherapy Worth a Shot? | ➤ .ppt | |
Dec 10, 2010 | Advanced Pancreatic Cancer: Anything on the Horizon? | ➤ .ppt | |
Feb 4, 2011 | Solitary Metastases | ➤ .ppt | |
Mar 25, 2011 | Lymph Node Dissection in Early Breast Cancer | ➤ .ppt | |
Sep 16, 2011 | Molecular Profiling as Guide to Therapy in Early Breast Cancer | ➤ .ppt | |
Feb 24, 2012 | Stage II Colon Cancer | ➤ .ppt | |
Mar 23, 2012 | Avastin and Breast Cancer: What Is the Fuss All About? | ➤ .ppt | |
Peles, Shachar | Sep 26, 2003 | Cutaneous T Cell Lymphoma | ➤ .ppt |
Feb 6, 2004 | An Unusual Aplastic (pure Red Cell Aplasia and Thymoma) | ➤ .ppt | |
Oct 29, 2004 | Angioimmunoblastic T-cell Lymphoma | ➤ .ppt | |
Dec 16, 2005 | Treatment of Early Stage Diffuse Large B Cell Lymphoma | ➤ .ppt | |
May 12, 2006 | Hematopoietic Stem Cell Transplant in CLL | ➤ .ppt | |
Pellini Ferreira, Bruna | Dec 22, 2017 | Heparin Induced Thrombocytopenia (HIT) Treatment | ➤ .pptx |
Feb 9, 2018 | Cell Tumor DNA in the Diagnosis and Follow-Up of NSCLC | ||
May 18, 2018 | FDG-PET Scan in the Assessment of Multiple Myeloma-Related Bone Disease | ➤ .pptx | |
Nov 16, 2018 | Del(5q) MDS | ➤ .pptx | |
Feb 8, 2019 | Urinary cfDNA in Lung Cancer Surveillance: Present and Future Directions | ||
Feb 7, 2020 | JAK Inhibitors in the Management of Adult Hemophagocytic Lymphohistiocytosis | ➤ .ppt | |
May 15, 2020 | Urinary Cell-Free DNA Analysis for Tumor Mutation Detection in Patients With Oligometastatic Colorectal Cancer | ||
Perkins, Stephanie | Oct 30, 2020 | The Role of Proton Therapy in Adult Cancers | |
Petersen, Gloria | Sep 23, 2016 | Genetic Susceptibility to Pancreatic Cancer: New Insights | |
Peterson, Lindsay | Apr 2, 2021 | Precision Nutrition in Cancer Care | |
Petrone, Giulia | Apr 14, 2023 | Newer Approaches to Improving the Health of Sickle Red Blood Cells | ➤ .pptx |
Phallen, Jill | May 12, 2023 | Liquid Biopsy Approaches and Cell-Free DNA Biology for Early Detection of Cancer | |
Picus, Joel | May 7, 2004 | 5 Alpha Reductase Inhibitors and Prostate Cancer | |
Oct 14, 2005 | New Targets for Prostate Cancer | ||
Sep 4, 2009 | Sleep Deprivation | ||
Jan 29, 2010 | History of the Division of Oncology: Filling in the Gaps | ➤ .ppt | |
May 17, 2013 | Intermittent Hormonal Therapy for Prostate Cancer | ||
Pillot, Giancarlo | Sep 12, 2003 | PET Scanning in Staging of Non-Small Cell Lung Cancer | ➤ .ppt |
Jan 30, 2004 | Adrenal Carcinoma | ➤ .ppt | |
Dec 10, 2004 | Low Grade Follicular Lymphomas | ➤ .ppt | |
Apr 8, 2005 | Predicting Risk in Early Stage Non-Small Cell Lung Cancer to Tailor Adjuvant Chemotherapy | ||
Jan 27, 2006 | Surgery for Abdominal Metastases in Colorectal Cancer | ➤ .ppt | |
May 5, 2006 | Update on Locally Advanced Non-Small Cell Lung Cancer | ➤ .ppt | |
Pizarro, Rigoberto | Oct 8, 2021 | Overview of Health Disparities in Cancer | |
Plass, Christoph | Nov 30, 2001 | Aberrant DNA Methylation Profiles in Cancer | |
Podany, Emily | Jun 9, 2023 | Hematologic Sequelae of Toxins in St. Louis and Impacts on Disadvantaged Communities | ➤ .pptx |
Pomerantz, Mark | Sep 15, 2006 | Hormones, Genes and Prostate Cancer Risk | |
Ponder, Kathy | Nov 1, 2002 | Gene Therapy for Hemophilia | ➤ .ppt |
Feb 13, 2004 | A Patient With Hypoxemia and Cyanosis (Hgb-M Saskatoon) | ➤ .ppt | |
Feb 11, 2005 | Treatments for Hemophilia A Patients With Inhibitors | ➤ .ppt | |
Feb 2, 2007 | New Treatments for Iron Overload | ➤ .ppt | |
Jun 5, 2009 | A 57 Year Old Filipino Man With a Hemoglobin of 3.3 | ➤ .ppt | |
Nov 16, 2012 | Chimeric Antigen Receptor (CAR)-Modified T Cells for Treatment of CLL | ➤ .pptx | |
Q | |||
R | |||
Raghavan, Srivatsan | Jan 28, 2022 | The Tumor Microenvironment Drives Cell State, Plasticity, and Drug Response in Pancreatic Cancer | |
Ramirez, Pablo | Mar 27, 2009 | Umbilical Cord Blood Transplantation in Acute Leukemias | ➤ .ppt |
Ramsingh, Giri | Nov 9, 2007 | Regulatory T-cells and Graft Versus Host Disease | ➤ .ppt |
Jan 18, 2008 | P53: New Twist to the Old Story | ➤ .ppt | |
Apr 25, 2008 | Endogenous Retroviruses: Evolution and Cancer | ➤ .ppt | |
Sep 5, 2008 | Genomic Instability and Multiple Mutations in Cancer | ➤ .ppt | |
Apr 3, 2009 | RNA Based Therapy | ➤ .ppt | |
Oct 9, 2009 | Cancer: a Darwinian Process | ➤ .ppt | |
Rao, Aarati | Sep 26, 2003 | Alloimmunization in Sickle Cell Disease | |
Dec 19, 2003 | FAP Gene and Hepatoblastoma | ➤ .ppt | |
Feb 20, 2004 | Familial Diamond-Blackfan Anemia | ➤ .ppt | |
Apr 9, 2004 | Beckwith-Wiedemann Syndrome/idiopathic Hemihypertrophy: Clinical Implications and Screening | ➤ .ppt | |
Rashidi, Armin | Nov 8, 2013 | Prognostic Significance and Treatment of CLL-Associated Autoimmune Cytopenias | ➤ .pptx |
Jan 17, 2014 | Allogeneic Hematopoietic Stem Cell Transplantation for Solid Tumors | ➤ .pptx | |
May 9, 2014 | Photopheresis in the Treatment of Graft-Versus-Host Disease | ➤ .pptx | |
Sep 12, 2014 | Bone Marrow Neuropathy | ➤ .pptx | |
Jan 23, 2015 | Double-Hit Lymphoma: An Exception to the Traditional NHL Rule? | ➤ .pptx | |
Apr 17, 2015 | TTP (Thiotepa) | ➤ .pptx | |
Apr 15, 2016 | Acute GvHD: Microbiome and Beyond | ➤ .pptx | |
Ratner, Lee | May 23, 2003 | Human T-cell Leukemia Virus and Adult T-cell Leukemia/lymphoma | ➤ .ppt |
Sep 19, 2003 | Adult T Cell Leukemia/lymphoma | ➤ .ppt | |
Sep 17, 2004 | HTLV-1 and ITP | ➤ .ppt | |
Feb 22, 2008 | Overview of Research in the Molecular Oncology Section | ➤ .ppt | |
Apr 13, 2018 | Pathogenesis and Treatment of Human T-Cell Leukemia Virus Associated Malignancy | ||
Ravi, Arvind | Jan 13, 2023 | Integrative Approaches to Understanding Therapeutic Response and Resistance | |
Read, Will | Sep 7, 2001 | Does SV40 Cause Cancer in Humans? | |
Mar 1, 2002 | Thiazolidinediones, PPARs, and Cancer | ||
Jun 7, 2002 | Bronchioloalveolar Carcinoma | ||
May 9, 2003 | Tonsillar Cancer | ||
Regenbogen, Tom | Oct 10, 2014 | Continued Cigarette Smoking after Cancer Diagnosis | ➤ .pptx |
Nov 21, 2014 | JAK/STAT Pathway in Solid Tumors | ➤ .pptx | |
Mar 6, 2015 | Thrombopoietin Receptor Agonists: Expanding Indications | ➤ .pptx | |
Sep 4, 2015 | Human Papillomavirus and Cancer of the Oropharynx | ➤ .pptx | |
Mar 25, 2016 | Steroid Refractory ITP: Choosing Splenectomy? | ➤ .pptx | |
May 27, 2016 | The Clinical Utility of Extended Gene Panel Sequencing in Oncology | ➤ .pptx | |
Dec 9, 2016 | Non-Surgical Liver Directed Therapy | ||
Reimers, Melissa | Sep 7, 2018 | Precision Medicine and Immunotherapy in Metastatic Prostate Cancer | |
Nov 5, 2021 | Updates and Recent Advances in Renal Cell Carcinoma | ||
Ribeiro Pereira, Patricia | Oct 29, 2021 | Non-Invasive Nuclear Imaging of Cancer Biology to Convert Non-Responders Into Responders | |
Riedell, Peter | Oct 18, 2013 | Novel Therapies for Peripheral T-cell Lymphomas | ➤ .pptx |
Jan 24, 2014 | Rituximab Associated Hepatitis B Virus Reactivation | ➤ .pptx | |
May 23, 2014 | Classic Kaposi Sarcoma | ➤ .pptx | |
Sep 19, 2014 | B-Cell Receptor Signaling in Lymphoid Malignancies | ➤ .pptx | |
Nov 7, 2014 | Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia | ➤ .pptx | |
May 1, 2015 | Autologous Transplant in Autoimmune Disease | ➤ .pptx | |
Oct 2, 2015 | Optimizing Therapy for Mantle Cell Lymphoma | ➤ .pptx | |
Rigden, Caron | Sep 24, 2004 | Primary Mediastinal B-cell Lymphoma | ➤ .ppt |
Feb 11, 2005 | Glioblastoma Multiforme | ➤ .ppt | |
Feb 10, 2006 | Treatment of Advanced and Metastatic Gastric Cancer | ➤ .ppt | |
May 4, 2007 | Her2 Positive Breast Cancer: Beyond Trastuzumab | ➤ .ppt | |
Rodriguez, Luis | Oct 5, 2001 | Metallic Endolumenal Stents for Colorectal Cancer | |
Nov 2, 2001 | Pulmonary Artery Sarcoma Masquerading as Pulmonary Embolism | ||
Feb 15, 2002 | Chemotherapy for Androgen-Independent Prostate Cancer | ||
Apr 19, 2002 | Malignant Thymoma | ||
Oct 18, 2002 | Monoclonal Antibodies Targeting Epidermal Growth Factor Receptor | ➤ .ppt | |
May 2, 2003 | Neoadjuvant Therapy for Rectal Cancers | ➤ .ppt | |
Jun 13, 2003 | Oncology Trivia (with Pastries) | ➤ .ppt | |
Rokkam, Aruna | Oct 30, 2009 | Green Tea and Cancer | |
Nov 20, 2009 | Radioembolization of Hepatic Metastases From Colorectal Cancer | ➤ .ppt | |
Dec 11, 2009 | Merkel Cell Carcinoma | ➤ .ppt | |
Apr 2, 2010 | Hepatic Veno-Occlusive Disease (Sinusoidal Obstruction Syndrome) | ➤ .ppt | |
Apr 30, 2010 | Bisphosphonates for Adjuvant Treatment | ➤ .ppt | |
Oct 29, 2010 | Clinical Imaging of the Tumoral Expression of OATP1B3 | ➤ .ppt | |
Apr 22, 2011 | Carcinoid Tumors | ➤ .ppt | |
May 6, 2011 | Radiation Resistance | ➤ .ppt | |
Mar 23, 2012 | Colorectal Liver Metastases | ➤ .ppt | |
May 18, 2012 | Vitamin D: Evidence for Cancer Prevention and Treatment | ➤ .pptx | |
Romee, Rizwan | Mar 27, 2015 | Introduction to Haploidentical Transplantation | ➤ .pptx |
Apr 28, 2017 | Bone Marrow Failure | ➤ .pptx | |
Roncarolo, Maria-Grazia | Feb 17, 2017 | T Regulatory Cells in Immunomediated Diseases: From Bench to Bedside and Beyond | |
Rondina, Matthew | Jan 31, 2020 | Platelet Transcriptomics as Discovery Tools in Human Health and Disease | |
Rooney, Melissa | Oct 14, 2011 | The Role of L-Asparaginase in the Treatment of Adult ALL | ➤ .ppt |
Feb 10, 2012 | The Role of Bortezomib in the Treatment of AL Amyloidosis | ➤ .ppt | |
Apr 13, 2012 | Waldenström's Macroglobulinemia | ➤ .ppt | |
Feb 22, 2013 | Malignancy in Pregnancy | ➤ .pptx | |
Apr 19, 2013 | Initial Management of Advanced Ovarian Cancer | ➤ .pptx | |
Sep 13, 2013 | Nodular Lymphocyte Predominant Hodgkin Lymphoma | ➤ .pptx | |
May 23, 2014 | Adjuvant Endocrine Therapy for Hormone Receptor Positive Breast Cancer | ➤ .pptx | |
Roop, Ryan | Oct 15, 2010 | Tyrosine Kinase Inhibitors in Newly Diagnosed Chronic Phase CML | ➤ .ppt |
Dec 17, 2010 | Circulating Tumor Cells and Their Role in Breast Cancer | ➤ .ppt | |
Feb 18, 2011 | An Overview of Bone Marrow Micrometastasis in Breast Cancer | ➤ .ppt | |
Mar 25, 2011 | Met Inhibitors and Solid Malignancies | ➤ .ppt | |
Apr 29, 2011 | What Is the Best Dose of Cytarabine in AML? | ➤ .ppt | |
Sep 9, 2011 | Targeted Therapies for Overcoming Endocrine Resistance in Breast Cancer | ➤ .ppt | |
Nov 11, 2011 | The Utility of PET Scans in Treating Lymphoma | ➤ .ppt | |
Apr 27, 2012 | Locally Advanced Bladder Cancer | ➤ .pptx | |
Sep 21, 2012 | Female Germ Cell Tumors | ➤ .pptx | |
Apr 12, 2013 | Systemic Therapy for Thyroid Cancer | ➤ .ppt | |
Rosol, Thomas | Feb 27, 2004 | Parathyroid Hormone-Related Protein: Role in Normal Biology, Cancer and Bone Metastasis | |
Rubin, Joshua | Feb 25, 2022 | Adapting Cancer Treatment to Sex Differences in Cancer Biology | |
Russler-Germain, David | Jun 19, 2020 | Bispecific Antibodies in Lymphoid Malignancies: Past, Present, and Future | |
Jan 15, 2021 | Integrating Genomics Into Lymphoma Treatment Strategies | ||
May 20, 2022 | Immunotherapy for Follicular Lymphoma: A Goldilocks Dilemma? | ||
Jan 27, 2023 | Follicular Lymphoma: New Insights, Treatments, and Opportunities | ||
S | |||
Saba, Raya | Feb 26, 2021 | Overview and Advances in Treatment of Mantle Cell Lymphoma | |
May 14, 2021 | Checkpoint Blockade Therapy in Lymphoma | ➤ .pptx | |
Oct 15, 2021 | Updates in Frontline Treatment of Chronic Lymphocytic Leukemia | ||
Feb 4, 2022 | Thrombotic Microangiopathy in Cancer Patients | ➤ .ppt | |
Feb 10, 2023 | Management of Diffuse Large B-Cell Lymphoma in Older Patients | ||
Sadler, Evan | Oct 11, 2002 | ADAMTS13 and Thrombotic Thrombocytopenic Purpura | |
Oct 10, 2003 | Potential Molecular Mechanism for Trousseau Syndrome | ➤ .ppt | |
Mar 26, 2004 | Local Experience in TTP | ➤ .ppt | |
Oct 1, 2004 | Update on ADAMTS13 | ➤ .ppt | |
Apr 14, 2006 | Rituximab for Autoimmune Diseases | ➤ .ppt | |
Aug 11, 2006 | Von Willebrand Disease and TTP | ➤ .ppt | |
Apr 13, 2007 | Stroke in a Nineteen Year Old Girl With Sickle Cell Disease | ➤ .ppt | |
Sep 28, 2007 | Overview of Research in the Hematology Division | ||
Sep 26, 2008 | Tick Bites, Fever, Pancytopenia | ➤ .ppt | |
Apr 5, 2013 | ADAMTS13 and TTP | ➤ .pptx | |
Aug 8, 2014 | Thrombotic Microangiopathies | ➤ .pptx | |
Aug 21, 2015 | Thrombotic Microangiopathies | ➤ .pptx | |
Jul 22, 2016 | Thrombotic Microangiopathies | ➤ .pptx | |
Nov 4, 2016 | Von Willebrand Disease | ➤ .pptx | |
Aug 11, 2017 | Thrombotic Microangiopathies | ➤ .pptx | |
Nov 10, 2017 | Von Willebrand Disease | ➤ .pptx | |
Sage, Julien | Sep 20, 2019 | Mechanisms of Small Cell Lung Cancer Metastasis | |
Saif Ur Rehman, Sana | Jan 8, 2016 | Anaplastic Lymphoma Kinase as a Therapeutic Target in NSCLC - Recent Advances and Future Perspectives | ➤ .pptx |
Apr 1, 2016 | Overcoming Resistance to HER- 2 Directed Therapy in Patients With Advanced HER-2 Positive Breast Cancer | ➤ .pptx | |
May 13, 2016 | Scleromyxedema | ➤ .pptx | |
Nov 18, 2016 | Chronic Neutrophilic Leukemia: Novel Mutations and Impact on Clinical Practice | ||
Apr 13, 2018 | Hypereosinophilia | ➤ .pptx | |
Aug 17, 2018 | Sickle Cell Anemia | ➤ .pptx | |
Mar 29, 2019 | Improving Quality of Care in Sickle Cell Disease | ➤ .pptx | |
Oct 4, 2019 | Approach to Hypereosinophilia | ➤ .pptx | |
Oct 18, 2019 | Sickle Cell Anemia | ➤ .pptx | |
Dec 13, 2019 | Hemophagocytic Lymphohistiocytosis | ➤ .pptx | |
Aug 14, 2020 | Thrombocytopenia in a Hospitalized Patient | ➤ .pptx | |
Sep 25, 2020 | Sickle Cell Anemia | ➤ .pptx | |
Jan 8, 2021 | ASH Review 2020: Sickle Cell Disease | ➤ .ppt | |
Aug 6, 2021 | Thrombocytopenia in Hospitalized Patients | ➤ .pptx | |
Oct 8, 2021 | Sickle Cell Anemia | ➤ .pptx | |
Jan 14, 2022 | ASH 2021 Review: Sickle Cell Anemia | ➤ .pptx | |
Mar 18, 2022 | Understanding Acute and Chronic Pain in Sickle Cell Disease | ➤ .pptx | |
Jul 29, 2022 | Thrombocytopenia in a Hospitalized Patient | ➤ .pptx | |
Oct 14, 2022 | Sickle Cell Anemia | ➤ .pptx | |
Mar 17, 2023 | Improving Quality of Care in Sickle Cell Disease | ➤ .pptx | |
Aug 4, 2023 | Thrombocytopenia in a Hospitalized Patient | ➤ .pptx | |
Saloura, Vassiliki | Apr 28, 2017 | WHSC1L1 as an Oncogenic Methyltransferase in Head and Neck Cancer: Progress Towards Clinical Translation | |
Sands, Mark | Jan 7, 2005 | Hematopoietic-Directed Gene Therapy for Lysosomal Storage Diseases | ➤ .ppt |
Sanfilippo, Kristen | Nov 5, 2010 | Anticoagulation for the Secondary Prevention of Venous Thromboembolism in Patients With Cancer | ➤ .ppt |
Dec 17, 2010 | Bisphosphonates and Survival in Multiple Myeloma | ➤ .ppt | |
Mar 18, 2011 | Thrombopoietin Receptor Agonists in Immune Thrombocytopenia | ➤ .ppt | |
May 6, 2011 | Transplant Associated Thrombotic Microangiopathy (TA-TMA) | ➤ .ppt | |
May 20, 2011 | Transfusion-Related Acute Lung Injury (TRALI) | ➤ .ppt | |
Oct 28, 2011 | Controversies in Pulmonary Hypertension and Sickle Cell Disease | ➤ .ppt | |
Dec 2, 2011 | Eculizumab in Atypical Hemolytic Uremic Syndrome | ➤ .ppt | |
Apr 27, 2012 | Venous Thromboprophylaxis in Ambulatory Cancer Patients | ➤ .ppt | |
Nov 2, 2012 | Muscle-Invasive Bladder Cancer: Non-Surgical Management | ➤ .pptx | |
Mar 1, 2013 | Management of Early Stage Hodgkin Lymphoma | ➤ .pptx | |
Oct 28, 2016 | Cancer Associated Thrombosis | ➤ .pptx | |
Aug 18, 2017 | Cancer Associated Thrombosis | ➤ .pptx | |
Aug 31, 2018 | Venous Thromboembolism | ➤ .pptx | |
Jan 4, 2019 | Cancer Associated Thrombosis: Prevention to Treatment | ||
May 22, 2020 | COVID-19 Coagulopathy and Venous Thromboembolism | ➤ .pptx | |
Jun 19, 2020 | Venous Thromboembolism | ➤ .pptx | |
Jan 8, 2021 | ASH Review 2020: Thrombosis | ➤ .ppt | |
Jun 17, 2022 | Anticoagulation Beyond 6 Months for Cancer-Associated Thrombosis - What Is the Data? | ➤ .pptx | |
Jan 20, 2023 | ASH Review 2022: Hemostasis and Thrombosis | ➤ .pptx | |
Feb 17, 2023 | Cancer-Associated Thrombosis (CAT): 20 Years of Change | ➤ .pptx | |
Schapiro, Melissa | Sep 23, 2011 | Post Transplant Lymphoproliferative Disorder: Risk Factors and Prognosis | ➤ .ppt |
Mar 16, 2012 | Shwachman-Diamond Syndrome | ➤ .ppt | |
Schell, Amy | Oct 5, 2012 | Autoimmune Complications of CLL | ➤ .pptx |
Feb 1, 2013 | Cancer-Related Fatigue | ➤ .pptx | |
Schrag, Deborah | Mar 3, 2017 | Pilots to Populations: Quality, Efficacy and Effectiveness of Rectal Cancer Treatment | |
Schreiber, Robert | Jan 6, 2012 | Translating Cancer Immunoediting Into Novel Cancer Immunotherapies | ➤ .pptx |
Schroeder, Mark | Oct 6, 2006 | Mysteries of the Mantle Zone: Good Is Bad and Bad Is Good Except in Mantle Cell | ➤ .ppt |
Feb 16, 2007 | Steroid Refractory Acute GVHD | ➤ .ppt | |
May 18, 2007 | Cancer Stem Cells: a Review and Implications for Novel Therapeutic Approaches | ➤ .ppt | |
Sep 14, 2007 | Advanced Hepatocellular Carcinoma After ASCO 2007 | ➤ .ppt | |
May 2, 2008 | Chronic GVHD: in Search of a Model to Understand Its Pathobiology | ➤ .ppt | |
Sep 5, 2008 | Donor Lymphocyte Infusions for the Treatment of Hematologic Malignancies | ➤ .ppt | |
Apr 24, 2009 | Hematopoietic Stem Cell Transplantation for MDS: Are We Putting the Cart Before the Horse | ➤ .ppt | |
May 15, 2015 | Curative Therapies for Sickle Cell Disease | ➤ .pptx | |
Schuettpelz, Laura | Feb 13, 2009 | Hemophagocytic Lymphohistiocytosis | ➤ .ppt |
Schwartz, Eric | Oct 22, 2021 | Financial Burdens Surrounding Oral Cancer Therapy | |
Sekhar, Jeevan | Feb 27, 2009 | Adult T Cell Lymphoma/Leukemia | ➤ .ppt |
Mar 20, 2009 | I Cured My Own GVHD | ➤ .ppt | |
May 1, 2009 | Pharmacologic Thrombopoiesis: Past, Present, and Future | ➤ .ppt | |
Sep 11, 2009 | Eltrombopag Therapy to Increase Platelet Aphersis Yields in Healthy Donors | ||
Mar 26, 2010 | Thrombopoietic Agents as an Adjunct for Stem Cell Mobilization | ➤ .ppt | |
Oct 15, 2010 | Targeting the Microenvironment of Pancreatic Cancer | ➤ .ppt | |
Shad, Manish | Dec 17, 2004 | An Update on Gastric Cancer | |
Sharifi, Nima | Jan 5, 2007 | Prostate Cancer: From TGF-beta Resistance to Androgen Independence | |
Sharpless, Norman | Mar 24, 2023 | Ending Cancer as We Know It: Forecasting Future Cancer Progress | |
Shea, Lauren | Jan 25, 2019 | Treatment of Brain Metastases in Non-Small Cell Lung Cancer | |
Apr 5, 2019 | Induction Therapy in Treatment-Related AML | ➤ .pptx | |
Nov 8, 2019 | Cold Agglutinin Disease | ➤ .pptx | |
May 1, 2020 | Treatment of PTLD: Current Approaches and Emerging Therapies | ||
Apr 2, 2021 | Maximizing Vaccine Response in Patients With Hematologic Malignancies | ➤ .pptx | |
Shenoy, Shalini | Feb 28, 2003 | Fas-Mediated Apoptosis in Pediatric Autoimmune Cytopenias | ➤ .ppt |
May 16, 2014 | Stem Cell Transplantation for Hemoglobinopathy - an Overview | ➤ .pptx | |
Siner, Joshua | Jun 10, 2022 | Non-Factor Therapies for Hemophilia: Update on Standards of Care and Novel Gene Based Strategies | ➤ .ppt |
Apr 7, 2023 | The Numbers All Go to XI: Disease, Discovery and Designing a New Class of Anticoagulant | ➤ .pptx | |
Sisk, Bryan | Dec 22, 2017 | Pediatric Hypereosinophilia | ➤ .pptx |
May 18, 2018 | PIK3CA-Related Overgrowth Spectrum (PROS) and Consumptive Coagulopathy | ➤ .pptx | |
Slade, Michael | Dec 18, 2020 | Assessing Allogeneic Transplant Eligibility in Older Adults | |
Jan 22, 2021 | Treatment of Acquired Aplastic Anemia | ➤ .pptx | |
Oct 29, 2021 | Immunoparesis in Multiiple Myeloma: Causes and Consequences | ➤ .pptx | |
May 27, 2022 | Why CARs Crash: CAR T Cell Treatment Failure and the PD-1/PD-L1 Axis | ||
Smukler, Avram | Nov 16, 2001 | Treatment of Aplastic Anemia | |
Dec 28, 2001 | Hepatoma Associated With AIDS | ||
Mar 29, 2002 | Arsenic Trioxide for Relapsed Acute Promyelocytic Leukemia | ||
Jun 14, 2002 | Autologous Stem Cell Transplantation for Hodgkin's Disease | ||
Sep 20, 2002 | Pegylated Filgrastim (G-CSF) | ||
Jan 3, 2003 | Management of Bone Metastases | ||
Dec 19, 2003 | Treatment for Recurrent Multiple Myeloma | ||
Snyder, Stacy | Feb 3, 2017 | Bilateral Wilms Tumor | ➤ .pptx |
Sorscher, Steven | Oct 22, 2004 | CHEK 2 and Human Tumors | |
May 5, 2006 | How Footpad Tumors in Cottontail Rabbits Led to HPV Vaccines | ➤ .ppt | |
Apr 27, 2007 | Rationale for Cancer Gene Therapy: Si Quaeris Peninsulam Amoenam Circumpice | ➤ .ppt | |
May 23, 2008 | Tumor-to-Tumor Metastases | ➤ .ppt | |
May 8, 2009 | Mitochondrial DNA and Cancer | ➤ .ppt | |
Nov 30, 2012 | Newly Described Common and Distinct Cancers Still Going by Old Names | ➤ .pptx | |
Jun 12, 2015 | How the Routine Recommended Molecular Tests Affect the Therapy of the Three Most Common Causes of US Cancer Mortality | ||
Souroullas, George | Jan 24, 2020 | Understanding the Role of EZH2 Mutations on Chromatin Dynamics and Oncogenesis | |
Spencer, David | May 10, 2019 | Understanding Aberrent DNA Methylation in Leukemia | |
Stein, Brady | Dec 18, 2020 | MPN Thrombosis, Bleeding and Special Situations | ➤ .pptx |
Stewart, Sheila | Feb 4, 2022 | Age-Related Stromal Changes Drive Tumor Progression | |
Stockerl-Goldstein, Keith | Oct 3, 2008 | Creating a Stem Cell Donor | ➤ .ppt |
Apr 27, 2018 | Diagnosis and Management of AL Amyloidosis | ➤ .pptx | |
Strosberg, Jonathan | Sep 14, 2018 | Overview of Treatments for Metastatic Gastroenteropancreatic Neuroendocrine Tumors | |
Subramanian, Janakiraman | Oct 12, 2007 | Lung Cancer in Never Smokers | ➤ .ppt |
Jan 25, 2008 | Thrombotic Microangiopathy After Stem Cell Transplant | ➤ .ppt | |
Jun 6, 2008 | Hemophagocytic Syndromes | ➤ .ppt | |
Jan 23, 2009 | Small Cell, Big Problem! Are Stem Cells the Root Cause? | ➤ .ppt | |
Oct 2, 2009 | EML4-ALK Fusion Gene in NSCLC | ➤ .ppt | |
Suresh, Rama | Nov 15, 2002 | Breast Ductal Lavage | ➤ .ppt |
Feb 7, 2003 | Pegylated Liposomal Doxorubicin (Doxil) in Metastatic Breast Cancer | ➤ .ppt | |
Apr 4, 2003 | Trastuzumab in Metastatic Breast Cancer | ➤ .ppt | |
Nov 7, 2003 | Adjuvant Hormonal Therapy for Breast Cancer...Beyond Tamoxifen | ➤ .ppt | |
Feb 20, 2004 | Relapsed Hodgkin's Disease | ➤ .ppt | |
May 19, 2006 | Fertility Preservation in Cancer Patients: ASCO Recommendations | ➤ .ppt | |
May 11, 2007 | Breast MRI | ➤ .ppt | |
May 2, 2008 | KRAS Mutation and the Efficacy of EGFR Monoclonal Antibodies in Metastatic Colorectal Cancer | ➤ .ppt | |
Apr 17, 2009 | Zoledronic Acid in Early Stage Breast Cancer | ➤ .ppt | |
Swanton, Charles | Jun 24, 2022 | Lung Cancer Evolution, Metastases and Immune Evasion: Insights From TRACERx | |
Sykes, Stephen | Jun 5, 2020 | The Role and Regulation of Serine Metabolism in Acute Myeloid Leukemia | |
T | |||
Tan, Ben | Apr 12, 2002 | Adjuvant Therapy of Pancreatic Cancer | |
Feb 6, 2004 | Colorectal Cancer: What's New? | ➤ .ppt | |
Oct 29, 2004 | Adjuvant Treatment for Colon Cancer | ➤ .ppt | |
Mar 30, 2007 | Treatment of Liver-Only Metastatic Colorectal Cancer | ➤ .ppt | |
Oct 5, 2018 | Localized Rectal Cancer: Navigating Shifting Paradigms | ||
Tap, William | Aug 19, 2016 | The Pit and the Pendulum, Emerging Therapies in Soft Tissue Sarcoma | |
Tarnawsky, Stefan | Apr 15, 2022 | Can the Gut Microbiome Predict Outcomes in Hematologic Malignancies? | ➤ .pptx |
Oct 28, 2022 | Update to the Prognostication and Classification of Myelodysplastic Syndromes | ||
Tarr, Phil | Nov 18, 2011 | Escherichia Coli O157:H7 and HUS: Pathophysiology, Management, and Public Health | |
Teague, Andrea | Sep 20, 2013 | Hepatosplenic Lymphoma | ➤ .pptx |
Feb 28, 2014 | Targeted Therapies in Sickle Cell Anemia | ➤ .pptx | |
Apr 18, 2014 | Metastatic Uveal Melanoma | ➤ .pptx | |
Sep 5, 2014 | Systemic Amyloidosis | ➤ .pptx | |
Nov 7, 2014 | Advances in Systemic Treatment for HER2+ Metastatic Breast Cancer | ➤ .pptx | |
Feb 13, 2015 | Gene Therapy in Hemophilia B | ➤ .pptx | |
Oct 9, 2015 | Monoclonal Antibodies in Multiple Myeloma | ➤ .pptx | |
Thibodeaux, Suzanne | Jun 15, 2018 | Cellular Therapy and Transfusion Medicine | ➤ .pptx |
Sep 14, 2018 | Principles of Therapeutic Apheresis | ➤ .pptx | |
Aug 30, 2019 | Therapeutic Apheresis and Hematology | ➤ .pptx | |
Sep 11, 2020 | Let’s Go for a Spin: An Introduction to Therapeutic Apheresis for Hematologists | ➤ .pptx | |
Sep 10, 2021 | Let's Go for a Spin: An Introduction to Therapeutic Apheresis for Hematologists | ➤ .pptx | |
Sep 2, 2022 | Let’s Go for a Spin: An Introduction to Therapeutic Apheresis for Hematologists | ➤ .pptx | |
Thomas, Ted | Oct 17, 2014 | Post-Thrombotic Syndrome: A Review of Non-Invasive Therapies for Prevention and Treatment | ➤ .pptx |
Dec 12, 2014 | The Jelly Belly: A Review of Pseudomyxoma Peritonei | ➤ .pptx | |
Mar 6, 2015 | Targeted Therapy in Advanced Gastric/Gastroesophageal Junction Adenocarcinomas | ➤ .pptx | |
Sep 4, 2015 | Treatment of Malignant Pheochromocytoma | ➤ .pptx | |
Dec 11, 2015 | Hemophilic Arthropathy: Impact of Initiating Prophylactic Factor Replacement in Therapy in Adults | ➤ .pptx | |
Mar 4, 2016 | Thrombosis in Androgen Therapy | ➤ .pptx | |
Apr 7, 2017 | Iron Deficiency Anemia: Cool Cases With Pagophagia | ➤ .pptx | |
Threadgill, David | Jan 26, 2007 | EGFR-Inhibition Therapies Are Dependent Upon Genetic and Environmental Context | |
Tollefsen, Doug | Jun 21, 2002 | Alpha-Hemoglobin Stabilizing Factor | ➤ .ppt |
Jun 11, 2004 | The Role of Hepcidin in Anemia of Chronic Disease | ➤ .ppt | |
Sep 23, 2005 | Does Low-Molecular-Weight Heparin Improve Survival of Cancer Patients? | ➤ .ppt | |
Aug 25, 2006 | Anticoagulants and HIT | ➤ .ppt | |
Mar 9, 2007 | Drug-Induced Thrombocytopenia | ➤ .ppt | |
Feb 22, 2008 | Thrombopoietic Agents for Treatment of ITP | ➤ .ppt | |
Aug 15, 2008 | Anticoagulants and HIT | ➤ .ppt | |
Aug 14, 2009 | Anticoagulants and HIT | ➤ .ppt | |
Sep 3, 2010 | Anticoagulants and HIT | ➤ .ppt | |
Jul 29, 2011 | Anticoagulants and HIT | ➤ .ppt | |
Aug 10, 2012 | Anticoagulation: Progress and Problems | ➤ .pptx | |
Dec 21, 2012 | Autoimmune Lymphoproliferative Syndrome (ALPS): a FAScinating Condition | ➤ .ppt | |
Jul 19, 2013 | Anticoagulant Therapy | ➤ .pptx | |
Aug 1, 2014 | Anticoagulant Therapy | ➤ .pptx | |
Jul 31, 2015 | Anticoagulant Therapy | ➤ .pptx | |
Aug 12, 2016 | Anticoagulant Therapy for Venous Thromboembolism | ➤ .pptx | |
Tomasson, Michael | Jun 14, 2002 | What Is the Role of Myc in Myeloid Leukemogenesis? | |
Jan 10, 2003 | Genomics of Acute Myelogenous Leukemia | ➤ .ppt | |
Nov 14, 2003 | Development of an Animal Model of T(4;14) Multiple Myeloma | ➤ .ppt | |
Apr 15, 2005 | Apoptosis and Transformation in a Model of Myc-Induced AML | ➤ .ppt | |
Nov 16, 2007 | Chromosome 13 Deletions in Multiple Myeloma | ||
Tran, David | Feb 29, 2008 | Tumor Dormancy | ➤ .ppt |
Apr 4, 2008 | Targeting Telomerase | ➤ .ppt | |
May 9, 2008 | Alcohol-Mediated Carcinogenesis | ➤ .ppt | |
Jan 9, 2009 | Glioblastoma Multiforme | ➤ .ppt | |
Apr 17, 2009 | Can Iron Deficiency Cause Thrombocytopenia? | ➤ .ppt | |
Apr 1, 2011 | Adult Primary CNS Tumors: the Medical Neuro-Oncology Perspective | ➤ .ppt | |
Mar 8, 2013 | Molecular Markers of Pseudoprogression in Gliomas | ➤ .ppt | |
Treon, Steven | Feb 19, 2021 | Treatment Advances in Waldenstrom's Macroglobulinemia | |
Truica, Cristina | Apr 2, 2004 | EGFR Modulation in Breast Cancer | |
Trujillo, Jonathan | Apr 21, 2023 | The Role of Cancer Cell-Intrinsic Hypoxia Inducible Factor (HIF) Activation in Tumor Immune Evasion | |
U | |||
Uy, Geoff | Sep 19, 2003 | Primary CNS Lymphoma | ➤ .ppt |
Jan 16, 2004 | Update of New Anticoagulants | ➤ .ppt | |
Apr 30, 2004 | CML and Resistance to Gleevec | ➤ .ppt | |
Apr 22, 2005 | Pulmonary Alveolar Proteinosis | ➤ .ppt | |
Jan 20, 2006 | Leukemia Stem Cells in AML | ➤ .ppt | |
Feb 19, 2016 | Two Interesting Cases on the BMT Service: 8p11 Myeloproliferative Syndome (EMS) Stem Cell Leukemia/Lymphoma | ➤ .pptx | |
V | |||
van den Brink, Marcel | Jan 27, 2017 | Strategies to Enhance Hematopoietic Stem Cell Transplantation | |
Van Tine, Brian | Nov 16, 2007 | TMPRSS2-ERG or ETV1 Fusions in Prostate Cancer | ➤ .ppt |
Jun 13, 2008 | SV40 and Mesothelioma | ➤ .ppt | |
Sep 12, 2008 | Chemotherapy During Pregnancy | ➤ .ppt | |
Feb 6, 2009 | New Pager System Orientation | ||
Oct 29, 2010 | Alveolar Soft Part Sarcoma and Sutent (Sunitinib Malate) | ➤ .ppt | |
Jan 5, 2018 | Sarcoma Metabolism | ||
Vedantham, Suresh | Dec 12, 2008 | Endovascular Thrombolytic Therapy for Acute DVT | ➤ .ppt |
Aug 27, 2010 | Endovascular Procedures in the Management of DVT | ➤ .ppt | |
Apr 14, 2017 | Prevention and Treatment of the Post-Thrombotic Syndrome | ➤ .pptx | |
Feb 12, 2021 | Catheter-Directed Intervention for Deep Vein Thrombosis and Post-Thrombotic Syndrome: Evolving Evidence, Insight, and Practice | ➤ .pptx | |
Verkruyse, Linda | Oct 4, 2002 | Hypereosinophilic Syndrome | |
Dec 20, 2002 | Rhabdomyosarcoma | ||
Mar 14, 2003 | Glioblastoma Multiforme | ➤ .ppt | |
Oct 3, 2003 | Angiosarcoma | ➤ .ppt | |
Jun 11, 2004 | Chemotherapy in Hormone Refractory Prostate Cancer | ➤ .ppt | |
Dec 10, 2004 | CMV Infection: Monitoring and Treatment in Bone Marrow and Stem Cell Transplantation | ➤ .ppt | |
Apr 29, 2005 | Mantle Cell Lymphoma: Current Treatment Strategies | ➤ .ppt | |
Verma, Priyanka | Mar 5, 2021 | Chromatin Accessibility: A New Vulnerability in BRCA-Mutant Cancers | |
Mar 17, 2023 | Targeting Base Damage Repair to Overcome Limitations of PARP Inhibitor Thaerapy in BRCA-Mutant Cancers | ||
Vij, Kiran | Jan 18, 2019 | Aggressive B-Cell Lymphomas | ➤ .pptx |
Oct 15, 2021 | Aggressive B-Cell Lymphomas | ➤ .pptx | |
Vij, Ravi | May 31, 2002 | Chromosomal Translocations in Multiple Myeloma | |
Sep 5, 2003 | Non-Myeloablative Transplantation | ➤ .ppt | |
Oct 8, 2004 | Hematopoietic Stem Cells for Cardiac Ischemia | ➤ .ppt | |
Oct 19, 2007 | Recent Trends in Allogeneic Hematopoietic Stem Cell Transplantation: CIBMTR Data | ➤ .ppt | |
May 15, 2009 | Hypomethylation: Turning on Silenced Genes and Silencing the Critics? | ➤ .ppt | |
Sep 1, 2017 | MM: AK47 or M24 | ||
Feb 18, 2022 | Multiple Myeloma: The Best Is Yet to Come! | ||
Vindigni, Alessandro | Feb 21, 2020 | Mechanisms of DNA Replication Stress Response to Chemotherapeutics | |
W | |||
Wagner-Johnston, Nina | Oct 26, 2007 | New Approaches to Monitoring Lymphoma | |
Wahl, Richard | Feb 24, 2017 | Quantitative Imaging to Phenotype Patients With Cancer | |
Wainwright, Derek | Mar 6, 2020 | Improving Survival by Reversing the Effects of Aging in Patients With Glioblastoma | |
Walgren, Richard | Feb 18, 2005 | Treatment of Refractory Idiopathic Thrombocytopenic Purpura | ➤ .ppt |
Oct 7, 2005 | Thrombotic Microangiopathy and Malignancy | ➤ .ppt | |
Jan 20, 2006 | Treatment of MDS With Azacitidine | ➤ .ppt | |
Mar 31, 2006 | Credentialing of Plantinum Pathway Genes | ||
Nov 10, 2006 | Epigenetic Changes in MDS | ➤ .ppt | |
Apr 6, 2007 | Pharmacogenomic Studies of Human Treatment-Related MDS and AML | ➤ .ppt | |
Mar 14, 2008 | MTOR Inhibition in Sarcoma | ➤ .ppt | |
Walling, Emily | Oct 11, 2013 | Congenital Fibrosarcoma | ➤ .pptx |
Walter, Matt | Sep 28, 2001 | CLL: Familial Vs. Environmental Factors | |
Nov 16, 2001 | Essential Thrombocythemia | ||
Apr 4, 2003 | Imatinib in Hypereosinophilic Syndrome | ➤ .ppt | |
Oct 21, 2005 | A Patient With AML and Shortness of Breath | ➤ .ppt | |
Nov 10, 2006 | Detection of Deletions and Amplifications in Primary AML Genomes | ||
Mar 27, 2009 | DNA Copy Number Alterations in Acute Leukemia | ➤ .ppt | |
Jun 23, 2017 | Genomics of Myelodysplastic Syndromes | ||
Apr 16, 2021 | Clonal Cytopenias and MDS | ||
Jan 21, 2022 | Clonal Evolution of Myelodysplastic Syndromes | ||
Apr 22, 2022 | Tumor Burden Monitoring in MDS | ||
Wang-Gillam, Andrea | Jun 13, 2008 | VEGFR1 and PIGF: Novel Targets in Angiogenesis | ➤ .ppt |
Jun 12, 2009 | Novel Targets in Pancreatic Cancer | ➤ .ppt | |
Nov 22, 2013 | New Developments in Pancreatic Cancer | ➤ .pptx | |
Wang, Tzu-Fei | Sep 24, 2010 | Maintenance Therapy in Multiple Myeloma | ➤ .ppt |
Oct 22, 2010 | The Changing Paradigm of Acute Myeloid Leukemia With Normal Cytogenetics | ➤ .ppt | |
Feb 11, 2011 | The Novel Oral Anticoagulants | ➤ .ppt | |
Mar 11, 2011 | Secondary Prevention of Venous Thromboembolism: Balancing Risks and Benefits | ➤ .ppt | |
May 13, 2011 | The Role of Anthracyclines in Her2 Positive Early Stage Breast Cancer | ➤ .ppt | |
Dec 16, 2011 | Obesity and Venous Thromboembolism | ➤ .ppt | |
Feb 17, 2012 | Hemophilia a With Inhibitors | ➤ .ppt | |
Mar 30, 2012 | Double-Hit B-cell Lymphoma | ➤ .ppt | |
Nov 16, 2012 | Bleeding Complications and Reversal of the New Oral Anticoagulants - the Controversial Yet Inevitable | ➤ .pptx | |
May 3, 2013 | Ibrutinib - the New Kid on the Block for B Cell Malignancies | ➤ .pptx | |
Waqar, Saiama | Oct 3, 2008 | Diagnostic Strategies for Carcinoma of Unknown Primary | ➤ .ppt |
Jan 16, 2009 | Primary Intraocular Lymphoma | ➤ .ppt | |
Mar 13, 2009 | Cutaneous Toxicities of Cancer Therapy | ➤ .ppt | |
May 22, 2009 | Evolving Treatment Paradigms for Stage III NSCLC | ➤ .ppt | |
Oct 23, 2009 | A Phase I/II Trial of Temsirolimus and Pemetrexed in Recurrent/Refractory Non-Small Cell Lung Cancer (NSCLC) | ||
Oct 8, 2010 | Maintenance Therapy in Advanced NSCLC | ➤ .ppt | |
Ward, Jeff | Oct 12, 2012 | PD-1 Inhibitors: Which Tumors Can Be Programmed for Death? | ➤ .pptx |
Jan 11, 2013 | Manipulation of Natural Killer Cell Inhibitory Receptors to Improve Outcomes in Allogeneic Stem Cell Transplantation | ➤ .pptx | |
Apr 12, 2013 | Beyond Myeloma: Lenalidomide as a Treatment Option in Hodgkin and Non-Hodgkin Lymphomas | ➤ .pptx | |
Oct 4, 2013 | The Antigenic Landscape of Carcinoma of the Lung | ➤ .pptx | |
Mar 21, 2014 | T-cell Exhaustion, a Means or an End? | ➤ .pptx | |
Apr 11, 2014 | T-cell Therapy for EBV-Associated Lymphoproliferative Disorders | ➤ .pptx | |
Sep 19, 2014 | The Abscopal Effect | ➤ .pptx | |
Mar 27, 2015 | Helping the Helpers: Boosting the Anti-Tumor Immune Response With Agonistic CD40 Antibodies | ➤ .pptx | |
Sep 25, 2015 | Old Controversies and New Options on the Horizon For The Management of Mesothelioma | ➤ .pptx | |
Apr 27, 2018 | Remodeling of Intratumoral Myeloid and Lymphoid Compartments Following Immune Checkpoint Blockade Therapy | ||
Warren, Julia | Feb 23, 2018 | Fanconi Anemia | ➤ .pptx |
Jan 21, 2022 | ASH 2021 Review: Bone Marrow Failure / Aplastic Anemia | ||
Wartman, Lukas | Nov 2, 2007 | Update on the Use of Epoetin and Darbepoetin | ➤ .ppt |
Dec 14, 2007 | Atypical HUS | ➤ .ppt | |
Sep 18, 2009 | Atypical Hemolytic Uremic Syndrome: an Update and Story of a Clinical Trial | ||
May 20, 2011 | Histone H3K27 Alterations and Cancer | ➤ .ppt | |
Watson, Mark | Dec 16, 2016 | Detection of Rare Tumor Cells | |
Weber, Jason | Mar 4, 2022 | Identification of Drivers and Vulnerabilities in Breast Cancer | |
Weilbaecher, Katherine | Feb 25, 2005 | Mechanisms of Bone Metastases | |
May 26, 2006 | Mechanisms of Bone Metastasis | ➤ .ppt | |
Apr 20, 2007 | G-CSF Enhances Bone Tumor Growth in Mice in an Osteoclast-dependent Manner | ➤ .ppt | |
Apr 22, 2016 | Antagonizing Integrin Beta3 Increases Immune Suppression in Cancer | ➤ .pptx | |
Oct 28, 2016 | Targeting Dormant and Growing Bone Metastases | ||
Nov 11, 2022 | Breast Cancer Metastasis in Bone: Insights Into Old Therapies and New Approaches | ||
Weinstock, George | Jan 14, 2011 | History of the Human Genome Project | ➤ .ppt |
Weiss, Mia | Feb 28, 2020 | Treatment of Metastatic Soft Tissue Sarcoma in the Era of Next Generation Sequencing | |
Welch, John | Oct 20, 2006 | APL and ATRA: Sure It Works, but How? | ➤ .ppt |
Jan 12, 2007 | CML: Goal Oriented Therapy | ➤ .ppt | |
May 11, 2007 | Post-Chemotherapy Nausea | ➤ .ppt | |
Nov 30, 2007 | How Much Blood Do You Need? | ➤ .ppt | |
Mar 7, 2008 | Splenic Lesions in Transformed Follicular Lymphoma | ➤ .ppt | |
Mar 13, 2009 | ITP and Thrombopoiesis | ➤ .ppt | |
May 8, 2009 | Waldenström's: Treatment and Transformation | ➤ .ppt | |
May 7, 2010 | Reprogramming Hematopoiesis by T(15;17) | ||
Feb 20, 2015 | Why Is AML a Disease of Growing Old? | ➤ .pptx | |
Oct 5, 2018 | Retinoids in Normal and Malignant Hematopoiesis | ➤ .pptx | |
Apr 5, 2019 | Integrating Next-Generation Sequencing Into AML and MDS Clinical Trials | ||
Sep 6, 2019 | Retinoids in Normal and Malignant Hematopoiesis | ➤ .pptx | |
Nov 13, 2020 | Subclonal and Transcriptional Responses of Decitabine in AML/MDS | ||
Feb 25, 2022 | Decitabine Responses in AML/MDS | ➤ .pptx | |
Westervelt, Peter | Sep 28, 2007 | Overview of Research in the BMT Section | |
White, Patrick | Jan 7, 2022 | Innovative Tools and Strategies for Enhancing Support for Your Oncology Patients and Caregivers | |
Widemann, Brigitte C. | Jan 19, 2018 | Development of Effective Therapies for NF1 Related Peripheral Nerve Sheath Tumors | |
Wildes, Tanya | Sep 23, 2005 | Treatment of Langerhans Cell Histiocytosis | ➤ .ppt |
Jan 6, 2006 | Chemotherapy and Fertility | ➤ .ppt | |
Apr 21, 2006 | Acute Leukemia and Intracerebral Hemorrhage | ➤ .ppt | |
Feb 9, 2007 | Targeted Therapy in Relapsed Hodgkin's Disease | ➤ .ppt | |
Apr 13, 2007 | Physical Activity and Cancer Risk | ➤ .ppt | |
Sep 7, 2007 | Fellows Protocol Discussion | ➤ .ppt | |
Feb 15, 2008 | Comorbidities and Geriatric Assessments in Older Adults With Cancer | ➤ .ppt | |
Aug 12, 2016 | Head and Neck Cancer | ||
May 5, 2017 | Age Is Just a Surrogate for Aging: Weaving the Principals of Geriatrics Into the Fabric of Oncology | ||
Williams, Kerry | Sep 22, 2006 | Medullary Renal Carcinoma - the Seventh Sickle Cell Nephropathy | ➤ .ppt |
Jan 12, 2007 | Irinotecan: Can We Predict Toxicity? | ➤ .ppt | |
Apr 20, 2007 | Burkitt's Lymphoma Mimicking a Gynecological Malignancy | ➤ .ppt | |
Jan 11, 2008 | BSA - Paradigm or Prehistoric | ➤ .ppt | |
Apr 25, 2008 | Helicobacter Pylori - the Good, the Bad and the Ugly | ➤ .ppt | |
Sep 12, 2008 | Sickle Cell Hepatopathy and the Role of Liver Transplantation | ➤ .ppt | |
Jan 9, 2009 | EWS-WT1 Gene Fusion: the Case of a Small Round Tumor | ➤ .ppt | |
Willis, Daniel | Sep 30, 2016 | Severe Congenital Neutropenia | ➤ .pptx |
Mar 31, 2017 | The Treatment of Neuroblastoma | ➤ .pptx | |
Wilson, Dave | Sep 2, 2011 | Pancytopenia and Bone Marrow Failure | ➤ .ppt |
Aug 31, 2012 | Pancytopenia and Bone Marrow Failure | ➤ .pptx | |
Aug 30, 2013 | Pancytopenia and Bone Marrow Failure | ➤ .ppt | |
May 4, 2018 | Recognizing Inherited BMF Syndromes in Adolescents and Young Adults | ➤ .ppt | |
Sep 28, 2018 | Bone Marrow Failure in Children, Adolescents, and Young Adults | ➤ .ppt | |
Wilson, David | Aug 23, 2019 | Bone Marrow Failure in Children, Adolescents, and Young Adults | ➤ .ppt |
Aug 7, 2020 | Bone Marrow Failure in Children, Adolescents, and Young Adults | ➤ .ppt | |
Aug 20, 2021 | Bone Marrow Failure in Children, Adolescents, and Young Adults | ➤ .ppt | |
Wong, Kwok-Kin | Apr 21, 2017 | The Use of Mouse Lung Cancer Models for Preclinical Testing of Novel Targeted and Immune Therapies | |
Wong, Terrence | Oct 7, 2011 | MicroRNAs as Novel Cancer Blood Biomarkers | ➤ .ppt |
Dec 2, 2011 | Using Proteomics to Elucidate Mechanisms of Tumor Chemo-Resistance | ➤ .ppt | |
Mar 9, 2012 | Long Non-Coding RNAs and Cancer – It's Not Just HOTAIR | ➤ .ppt | |
May 11, 2012 | The Role of Protein Stability and Partially Unfolded Conformations in Amyloidosis | ➤ .pptx | |
Feb 15, 2013 | Role of ERG Overexpression in Prostate Cancer Tumorigenesis | ➤ .pptx | |
Mar 15, 2013 | The Role of Tumor Heterogeneity in Cancer Tumorigenesis and Treatment | ➤ .pptx | |
Nov 15, 2013 | How the Nuclear Architecture May Influence Tumorigenesis | ➤ .pptx | |
Feb 7, 2014 | Vignettes in Systems Biology: Improving the Precision Guidance of Targeted Therapies | ➤ .pptx | |
Mar 20, 2015 | RNA Modifications and Cancer | ➤ .pptx | |
Wu, Jing | Mar 11, 2022 | Translational Research in Developing a CDK9 Inhibitor Towards a Glioma Treatment | |
X | |||
Xi, Jing | May 1, 2020 | Emerging Novel Therapies for HER2-Positive Metastatic Breast Cancer | |
Jan 22, 2021 | Myeloid Sarcoma: The Other Side of Acute Leukemia | ➤ .ppt | |
May 14, 2021 | The Emerging Therapeutic Landscape in Breast Cancer With Brain Metastases | ||
Apr 15, 2022 | A Silent Epidemic? – Disparities in Breast Cancer for Sexual and Gender Minority Women | ||
Xu, Amber | Nov 11, 2016 | Paraneoplastic Opsoclonus-Myoclonus Syndrome | |
Jan 27, 2017 | Smoldering Multiple Myeloma: Time to Change Management Paradigm? | ➤ .pptx | |
May 5, 2017 | Chronic Myeloid Leukemia: Combating Drug Resistance | ➤ .pptx | |
Jan 26, 2018 | Past, Present and Future of PARP Inhibition | ||
Dec 7, 2018 | Target Therapy in Non-Small Cell Lung Cancer | ||
Y | |||
Young, Andrew | Oct 9, 2020 | Clonal Hematopoiesis of Indeterminate and Determinate Potential | |
Oct 15, 2021 | Liquid Biopsy for Cancer Screening | ||
Apr 14, 2023 | Understanding Cancer Risk in Firefighters | ||
Z | |||
Zaretsky, Jesse | Feb 4, 2022 | HLH in Malignancy | ➤ .pptx |
Jun 30, 2023 | Checkpoint Immunotherapy, Beyond Anti-PD1 and CTLA4 | ||
Zhou, Alice | Oct 18, 2019 | Immunosuppression and Tumorigenesis: Lessons From Cyclosporine A on Angiogenesis | |
Oct 25, 2019 | Tumor Virology: HTLV-1 and ATLL | ➤ .pptx | |
Apr 23, 2021 | Immune Effector Cell-Associated Neurotoxicity (ICANS) | ➤ .ppt | |
May 28, 2021 | Multiple Myeloma and the Tumor Microenvironment: Focus on NK Cells and Therapeutic Exploitation | ||
May 6, 2022 | Overcoming Barriers to Treating Multiple Myeloma: Adoptive Cellular Therapy With Natural Killer Cells | ➤ .pptx | |
Zhou, Amy | Dec 13, 2013 | Role of Adjuvant Chemotherapy in Stage II Colon Cancer | ➤ .pptx |
Feb 28, 2014 | Stem Cell Transplantation in Sickle Cell Disease | ➤ .pptx | |
Mar 7, 2014 | Treatment of Acute Leukemia in Pregnancy | ➤ .pptx | |
Nov 21, 2014 | Novel Therapies in Myelofibrosis | ➤ .pptx | |
Jan 16, 2015 | Role of PD-1 Blockade in Hematologic Malignancies | ➤ .pptx | |
Apr 24, 2015 | Targeted Therapy in Metastatic Cholangiocarcinoma | ➤ .pptx | |
Dec 18, 2015 | Diagnosis and Treatment of RARS-T | ➤ .pptx | |
Sep 16, 2016 | Antibody Mediated Hematologic Conditions | ➤ .pptx | |
Nov 11, 2016 | Primary Myelofibrosis | ➤ .pptx | |
Sep 15, 2017 | Antibody Mediated Hematologic Conditions | ➤ .pptx | |
Feb 9, 2018 | Primary Myelofibrosis | ➤ .pptx | |
Oct 12, 2018 | Autoimmune Hemolytic Anemias and PNH | ➤ .pptx | |
Jan 25, 2019 | Antiphospholipid Antibody Syndrome | ➤ .pptx | |
Apr 19, 2019 | Primary Myelofibrosis | ➤ .pptx | |
Jan 10, 2020 | Autoimmune Hemolytic Anemia and PNH | ➤ .pptx | |
Oct 30, 2020 | Primary Myelofibrosis | ➤ .pptx | |
Mar 26, 2021 | Diagnosis and Clinical Management of Antiphospholipid Antibody Syndrome | ➤ .pptx | |
Jan 7, 2022 | ASH 2021 Review: Myeolproliferative Neoplasms | ➤ .pptx | |
Feb 11, 2022 | Myelofibrosis | ➤ .pptx | |
Feb 24, 2023 | Autoimmune Hemolytic Anemias | ➤ .pptx | |
Apr 21, 2023 | Myelofibrosis | ➤ .pptx | |
Ziga, Edward | Mar 12, 2010 | Testicular Microlithiasis in Children: Pre-malignant or Not | ➤ .ppt |
Apr 2, 2010 | Neuroblastoma in Infants | ➤ .ppt | |
May 21, 2010 | Sinus Venous Thrombosis in Neonates and Children | ➤ .ppt |